Sentence,class,file
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5179 | DOI: 10.1038/srep05179 9",Non-OADS,/arxiv_data1/oa_pdf/52/64/srep05179.PMC4046126.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/97/srep05191.PMC4046127.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5191 | DOI: 10.1038/srep05191 7",Non-OADS,/arxiv_data1/oa_pdf/99/97/srep05191.PMC4046127.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5189 | DOI: 10.1038/srep05189 5",Non-OADS,/arxiv_data1/oa_pdf/d2/22/srep05189.PMC4046128.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/17/srep05176.PMC4046129.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5176 | DOI: 10.1038/srep05176 10",Non-OADS,/arxiv_data1/oa_pdf/9a/17/srep05176.PMC4046129.pdf
"According to the database of genomic variants, the duplication has not been found in the normal population (http://projects.tcag.ca/ variation/).",Non-OADS,/arxiv_data1/oa_pdf/5e/7e/srep05180.PMC4046130.pdf
"MLPA .A custom MLPA probe was designed with the assistance of the online H- MAPD MLPA custom probe designer software (http://bioinform.arcan.stonybrook.edu/mlpa2/cgi-bin/mlpa.cgi) and designed to bind within the duplicated region on chromosome 1p34.3 (Specifically at bp position: 1 539,488,298–39,488,364; HG18).",Non-OADS,/arxiv_data1/oa_pdf/5e/7e/srep05180.PMC4046130.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5e/7e/srep05180.PMC4046130.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5180 | DOI: 10.1038/srep05180 7",Non-OADS,/arxiv_data1/oa_pdf/5e/7e/srep05180.PMC4046130.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5190 | DOI: 10.1038/srep05190 7",Non-OADS,/arxiv_data1/oa_pdf/5c/da/srep05190.PMC4046131.pdf
"ISBN 3- 900051-07-0 , URL http://www.R-project.org (2014).",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/srep05187.PMC4046132.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/e1/srep05187.PMC4046132.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5187 | DOI: 10.1038/srep05187 6",Non-OADS,/arxiv_data1/oa_pdf/9a/e1/srep05187.PMC4046132.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/80/f3/srep05194.PMC4046133.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5194 | DOI: 10.1038/srep05194 13",Non-OADS,/arxiv_data1/oa_pdf/80/f3/srep05194.PMC4046133.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/72/srep05186.PMC4046134.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Figure 5 |TEM image and diffraction pattern of a microsphere of another material.",Non-OADS,/arxiv_data1/oa_pdf/ed/72/srep05186.PMC4046134.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/49/f7/srep05185.PMC4046136.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5185 | DOI: 10.1038/srep05185 9",Non-OADS,/arxiv_data1/oa_pdf/49/f7/srep05185.PMC4046136.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/27/srep05045.PMC4046149.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5045 | DOI: 10.1038/srep05045 5",Non-OADS,/arxiv_data1/oa_pdf/51/27/srep05045.PMC4046149.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5192 | DOI: 10.1038/srep05192 7",Non-OADS,/arxiv_data1/oa_pdf/f2/b9/srep05192.PMC4046162.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5153 | DOI: 10.1038/srep05153 13",Non-OADS,/arxiv_data1/oa_pdf/41/b4/srep05153.PMC4046171.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2013.12.006Abbreviations: Apaf-1, apoptosis protease activating factor-1; BSA, bovine serum albumin; BSO, buthionine-[ S,R]sulfoximine; CA-AM, calcein-acetoxymethyl ester; CA-Fe, CA-bound iron; CM, conditioned media; DFO, desferrioxamine mesylate;DMSO, dimethyl sulfoxide; DPBS, Dulbecco ’s phosphate-buffered saline; DTNB, 5,5 0-dithiobis(2-nitrobenzoic acid); EDTA, ethylenediaminetetraacetic acid; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; Ft, ferritin; FtH, ferritin heavy chain; FtL, ferritin light chain; FtMt, mitochondrial ferritin; GPx,glutathione peroxidase; GR, glutathione reductase; GSH, reduced glutathione;h, hour(s); H 2O2, hydrogen peroxide; IR, ionizing radiation; IRP, iron regulatory protein; Kd, dissociation constant; LIP, labile iron pool; LL, lower left quadrant; min, minute(s); NADPH, reduced nicotinamide adenine dinucleotide phosphate; NR,neutral red;·OH, hydroxyl radical; PI, propidium iodide; PNG, glucose-free EMEM media containing pyruvate; RA, rheumatoid arthritis; ROS, reactive oxygen species; SD, standard deviation; SFM, serum-free media; SIH, salicylaldehyde isonicotinoyl hydrazone; TBHP, tert-butyl-hydroperoxide; TfR, transferrin receptor; UVA, ultra- violet A nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC4046229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5178 | DOI: 10.1038/srep05178 6",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/srep05178.PMC4046261.pdf
",http://archiv.ub.",Non-OADS,/arxiv_data1/oa_pdf/77/98/srep05175.PMC4046262.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Mu¨ller, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/77/98/srep05175.PMC4046262.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5175 | DOI: 10.1038/srep05175 11",Non-OADS,/arxiv_data1/oa_pdf/77/98/srep05175.PMC4046262.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/1b/srep05170.PMC4046349.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5170 | DOI: 10.1038/srep05170 5",Non-OADS,/arxiv_data1/oa_pdf/b2/1b/srep05170.PMC4046349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpIntegrated Blood Pressure Control 2014:7 19–28Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  19Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IBPC.S5903 0Phases in development of an interactive mobile  phone-based system to support self-management  of hypertension Inger hallberg1,11 Charles taft1,11 Agneta Ranerup2,11 Ulrika Bengtsson1,11   Mikael hoffmann3,10   Stefan höfer4 dick Kasperowski5 Åsa Mäkitalo6 Mona lundin6 lena Ring7,8   Ulf Rosenqvist9 Karin Kjellgren1,10,11 1Institute of health and Care Sciences,   2 department of Applied Information  technology, University of gothenburg,   gothenburg, 3the N ePI Foundation,   linköping, Sweden; 4department of  Medical Psychology, Innsbruck Medical  University, Innsbruck, Austria; 5department  of Philosophy, linguistics and theory  of Science, 6department of education,   Communication and learning, University  of gothenburg, gothenburg, 7Centre  for Research ethics and Bioethics,   Uppsala University, 8department of Use  of Medical Products, Medical Products  Agency, Uppsala, 9department of Medical  Specialist and department of Medical and  health Sciences, linköping University,   Motala, 10department of Medical and  health Sciences, linköping University,   linköping, 11Centre for Person-Centred  Care, Sahlgrenska Academy, University of  gothenburg, gothenburg, Sweden Correspondence: Inger hallberg   Institute of health and Care Sciences,   Sahlgrenska Academy, University   of gothenburg, Box 457, Se-405 30,   gothenburg, Sweden   tel +46 31 786 6107   Fax +46 31 786 6050   email i nger.hallberg@gu.s eAbstract:  Hypertension is a significant risk factor for heart disease and stroke worldwide.",Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
"A communication system for  mobile phones (with platforms, such as Java Micro Edition,  iOS, Android, and [from 2013] also Windows Phone), Cir - cadian Questions (CQ), developed by 21st Century Mobile,  Stockholm, Sweden, ( http://www.cqmobil.s e), was adapted  for use in this study.",OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
A distinct rise in blood pressure can  be seen when the patient did not take the antihypertensive drug the communication system for mobile phones Circadian Questions (CQ) was used ( http://www.cqmobil.se ).,Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
"Available from: http://www.who.int/chp/knowledge/publications/adher - ence_report/en/index.htm l. Accessed April 2, 2014.",OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
"Available from: http://www.ispor.org/workpaper/FDA%20PRO%20 Guidance.pd f. Accessed April 2, 2014.",Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
Available from: http://www.wma.,Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
Available from: http://clinicaltrials.gov/show/NCT0151030 1.,Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/3f/ibpc-7-019.PMC4046514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/06/c1/ibpc-7-029.PMC4046515.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpIntegrated Blood Pressure Control 2014:7 29–34Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  29RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S5953 5Aortic stiffness: pathophysiology, clinical  implications, and approach to treatment Salil Sethi Oscar Rivera Rene Oliveros Robert Chilton University of Texas Health Science  Center, San Antonio, TX, USA Correspondence: Robert Chilton   University of Texas Health Science  Center, Department of medicine,  Division of Cardiology, 7703 Floyd Curl  Drive, San Antonio, TX 78229, USA   email chiltonr@gmail.co mAbstract:  Aortic stiffness is a hallmark of aging, and classic cardiovascular risk factors play a  role in accelerating this process.",Non-OADS,/arxiv_data1/oa_pdf/06/c1/ibpc-7-029.PMC4046515.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/06/c1/ibpc-7-029.PMC4046515.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/c1/ibpc-7-029.PMC4046515.pdf
"E.Edlin, Anas Nader and Cesare M. N.Terracciano* Address: National Heart andLung Institute, Imperial College London, Imperial College Road, South Kensington, London, SW7 2AZ, UK *Corresponding author: Cesare MN Terracciano (c.terracciano@imperial.ac.uk) F1000Prime Reports 2014, 6:27(doi:10.12703/P6-27) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/27 Abstract Heart failure (HF) isagrowing cause ofmorbidity andmortality globally.,Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Page 2of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:27 http://f1000.com/prime/reports/m/6/27",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Importantly, LVAD therapy hasalso been shown toenhance SERCA expression (inone study, enhanced SRCa2+ stores were required forclinical recovery [19]), which demonstrates how theinterplay of Page 3of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:27 http://f1000.com/prime/reports/m/6/27",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:27 http://f1000.com/prime/reports/m/6/27",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:27 http://f1000.com/prime/reports/m/6/27",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:27 http://f1000.com/prime/reports/m/6/27",Non-OADS,/arxiv_data1/oa_pdf/35/37/biolrep-06-27.PMC4046563.pdf
"Women Birth 2013, Available  from: http://www.dx.doi.org/10.1016/j.wombi.",OADS,/arxiv_data1/oa_pdf/25/a9/IJEM-17-593.PMC4046590.pdf
Available from: http://www.mciindia.org/informationdesk  [Last  accessed on 2013 Jul 15].,OADS,/arxiv_data1/oa_pdf/bf/ff/IJEM-17-599.PMC4046595.pdf
Available from: http://www.natboard.edu.in [Last accessed on 2013  Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/bf/ff/IJEM-17-599.PMC4046595.pdf
Available from: http://www.framinghamheartstudy.org/risk/index.,Non-OADS,/arxiv_data1/oa_pdf/da/ec/IJEM-17-601.PMC4046612.pdf
Available from: http://www.dtu.o ×.ac.uk/riskengine/[Last accessed  2013 Sept 17].,Non-OADS,/arxiv_data1/oa_pdf/da/ec/IJEM-17-601.PMC4046612.pdf
Available from: http://www.shef.ac.uk/FRAX [Last accessed  2013 Sept 17].,Non-OADS,/arxiv_data1/oa_pdf/da/ec/IJEM-17-601.PMC4046612.pdf
Available from: http://www.qfracture.org/index.php [Last accessed  2013 Sept 17].,Non-OADS,/arxiv_data1/oa_pdf/da/ec/IJEM-17-601.PMC4046612.pdf
Available from: http://www.formatio‑reticularis.de/burch‑wartofsky.,Non-OADS,/arxiv_data1/oa_pdf/da/ec/IJEM-17-601.PMC4046612.pdf
Available from: http://www.idf.org/diabetesatlas [Last accessed on  2013 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/9c/5b/IJEM-17-674.PMC4046615.pdf
Available from: http://www.auburn.,Non-OADS,/arxiv_data1/oa_pdf/9c/5b/IJEM-17-674.PMC4046615.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial License August 2013 |  78  | e50358 | Page 1 of 13Video Article Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking Evan D. Morris1,2,3,4, Su Jin Kim1,3, Jenna M. Sullivan1,3,4, Shuo Wang3,4, Marc D. Normandin5, Cristian C. Constantinescu6, Kelly P. Cosgrove1,2,3 1Diagnostic Radiology, Yale University 2Psychiatry, Yale University 3Yale PET Center, Yale University 4Biomedical Engineering, Yale University 5Nuclear Medicine, Massachusetts General Hospital 6Radiological Sciences, University of California, Irvine Correspondence to: Evan D. Morris at evan.morris@yale.edu URL: http://www.jove.com/video/50358 DOI: doi:10.3791/50358 Keywords: Behavior, Issue 78, Neuroscience, Neurobiology, Molecular Biology, Biomedical Engineering, Medicine, Anatomy, Physiology, Image Processing, Computer-Assisted, Receptors, Dopamine, Dopamine, Functional Neuroimaging, Binding, Competitive, mathematical modeling (systems analysis), Neurotransmission, transient, dopamine release, PET, modeling, linear, time-invariant, smoking, F-test, ventral-striatum, clinical techniques Date Published: 8/6/2013 Citation: Morris, E.D., Kim, S.J., Sullivan, J.M., Wang, S., Normandin, M.D., Constantinescu, C.C., Cosgrove, K.P.",Non-OADS,/arxiv_data1/oa_pdf/99/9b/jove-78-50358.PMC4046621.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50358/ Introduction Despite overwhelming evidence of the medical risks, tobacco smoking is still a major health problem.",Non-OADS,/arxiv_data1/oa_pdf/99/9b/jove-78-50358.PMC4046621.pdf
2013 http://www.aaos.org/research/orthocensus/ census.asp.,OADS,/arxiv_data1/oa_pdf/4e/0d/10.1177_2041731414536573.PMC4046808.pdf
"APIC, http://www.apic.org/Resource_/ EliminationGuideForm/34e03612-d1e6-4214-a76b- e532c6fc3898/File/APIC-Ortho-Guide.pdf (2010).",OADS,/arxiv_data1/oa_pdf/4e/0d/10.1177_2041731414536573.PMC4046808.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(10): 813–817 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.819387 RESEARCH PAPER Self-reported function and disability in late life – cross-cultural adaptation and validation of the Swedish version of the late-life function and disability instrument Kirsti Skavberg Roaldsen1,2, Alexandra Halvarsson1,3, Belinda Sarlija3, Erika Franzen1,3, and Agneta Sta ˚hle1,3 1Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Stockholm, Sweden, 2Sunnaas Rehabilitation Hospital, Department of Research, Oslo, Norway, and3Karolinska University Hospital, Department of Physical Therapy, Stockholm, Sweden Abstract Purpose : To translate and perform a cross-cultural adaptation of the Late-Life Function and Disability Instrument (LLFDI) to Swedish, to investigate absolute and relative reliability, concurrent validity, and floor and ceiling effects within a Swedish-speaking sample ofcommunity-dwelling older adults with self-reported balance deficits and fear of falling.",Non-OADS,/arxiv_data1/oa_pdf/3f/69/DRE-36-813.PMC4046868.pdf
Available from http://sph.bu.edu/HDRI/llfdi/menu-id-617771.html [last accessed 15 February 2012].,Non-OADS,/arxiv_data1/oa_pdf/3f/69/DRE-36-813.PMC4046868.pdf
Available from: http://investor.osiris.com/ 2012 Sep 05.,Non-OADS,/arxiv_data1/oa_pdf/4a/4f/COP-11-310.PMC4046870.pdf
"http://informahealthcare.com/amy ISSN: 1350-6129 (print), 1744-2818 (electronic) Amyloid, 2014; 21(2): 113–119 !2014 Informa UK Ltd. DOI: 10.3109/13506129.2014.894908 ORIGINAL ARTICLE Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs Nina Norgren1, Malin Olsson1, Hanna Nystro ¨m2,B oG o ¨ran Ericzon3, Marie de Tayrac4,5,6, Emmanuelle Genin7,8, Violaine Plante ´-Bordeneuve9,10, and Ole B Suhr1 1Department of Public Health and Clinical Medicine,2Department of Surgical and Perioperative Sciences, Umea ˚University, Umea ˚, Sweden, 3Division of Transplantation Surgery, Karolinska Institutet, Stockholm, Sweden,4Centre National de la Recherche Scientifique (CNRS), Unite ´mixte de recherche ´– UMR 6290, Institut Ge ´ne´tique et De ´veloppment de Rennes, Rennes, France,5Faculte ´de Me ´decine, Universite ´Rennes 1, UEB – Universite ´ europe ´enne de Bretagne, Biosit, Rennes, France,6CHU – Centre Hospitalier Universitaire de Rennes, Service de Ge ´ne´tique Mole ´culaire et Ge ´nomique, Rennes, France,7INSERM UMR1078, Brest, France,8CHRU Brest, France,9Department of Neurology, Reference Center for Neuromuscular Disease and Amyloidosis, Henri Mondor University Hospital, Creteil, France, and10INSERM UMR955-Team 10, Paris Est University, Paris, France Abstract Introduction : Hereditary transthyretin amyloidosis (ATTR) is a genetic disease caused by a point mutation in the TTR gene that causes the liver to produce an unstable TTR protein.",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/AMY-21-113.PMC4046871.pdf
ErmineJ software (http://erminej.chibi.ubc.ca/) [20] was used for the gene list analysis.,OADS,/arxiv_data1/oa_pdf/ab/f5/AMY-21-113.PMC4046871.pdf
"http://informahealthcare.com/bij ISSN: 0269-9052 (print), 1362-301X (electronic) Brain Inj, 2014; 28(7): 879–895 !2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/95/BIJ-28-879.PMC4046872.pdf
"Available online at: http://www.cdc.gov/ncipc/ pub-res/tbi_in_us_04/tbi_ed.htm, accessed July 27, 2012.",OADS,/arxiv_data1/oa_pdf/be/95/BIJ-28-879.PMC4046872.pdf
"Available online at: http://www.dvbic.org/dod-worldwide-numbers-tbi, accessed July 5, 2012.",OADS,/arxiv_data1/oa_pdf/be/95/BIJ-28-879.PMC4046872.pdf
"Available online at: https://opencrs.com/document/RS22452/, accessed July 5, 2012.",Non-OADS,/arxiv_data1/oa_pdf/be/95/BIJ-28-879.PMC4046872.pdf
"Available online at: http://www.nlm.nih.gov/research/visible/visi- ble_human.html, accessed January 30, 2013.",OADS,/arxiv_data1/oa_pdf/be/95/BIJ-28-879.PMC4046872.pdf
"http://informahealthcare.com/xen ISSN: 0049-8254 (print), 1366-5928 (electronic) Xenobiotica, 2014; 44(6): 570–578 !2014 Informa UK Ltd. DOI: 10.3109/00498254.2013.852705 RESEARCH ARTICLE The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease Mohammad A. Aminzadeh1*, Scott A. Reisman2*, Nosratola D. Vaziri1, Mahyar Khazaeli1, Jun Yuan1, and Colin J. Meyer2 1Division of Nephrology and Hypertension, Schools of Medicine and Biological Science, University of California-Irvine, Orange, CA, USA, and 2Reata Pharmaceuticals, Irving, TX, USA Abstract 1.",Non-OADS,/arxiv_data1/oa_pdf/bb/41/XEN-44-570.PMC4046874.pdf
"Descriptions of the panels with accession numberscan be found at http://www.panomics.com.Thioredoxin reductase 1 (Txnrd1), thioredoxin 1 (Txn1) andperoxiredoxin 1 (Prdx1) were quantified.",Non-OADS,/arxiv_data1/oa_pdf/bb/41/XEN-44-570.PMC4046874.pdf
"Retrieved July 19, 2013, from http://www.ho- melesshub.ca/Library/View.aspx?id=34963.",Non-OADS,/arxiv_data1/oa_pdf/d8/a3/DEP-21-244.PMC4046876.pdf
"Retrieved June 5, 2013 from the National Documentation Centre on Drug Use Web site http://www.drugsandalcohol.ie/11724/.",OADS,/arxiv_data1/oa_pdf/d8/a3/DEP-21-244.PMC4046876.pdf
"Retrieved June 14, 2013, from http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2011/summary-sommaire-eng.php#a2.",Non-OADS,/arxiv_data1/oa_pdf/d8/a3/DEP-21-244.PMC4046876.pdf
"Retrieved June 5, 2013, from: http://www.primarycaresafetynet.ie/uploaded_documents/Safetynet_Methadone_Programme_Review_2011.pdf.",Non-OADS,/arxiv_data1/oa_pdf/d8/a3/DEP-21-244.PMC4046876.pdf
"Retrieved June 14, 2013 from: http://www12.statcan.gc.ca/ census-recensement/2011/dp-pd/hlt-fst/pd-pl/Table-Tableau.cfm?LANG=Eng&T=101&S=50&O=A.",OADS,/arxiv_data1/oa_pdf/d8/a3/DEP-21-244.PMC4046876.pdf
Available from http://www.mencap.org.uk/sites/default/files/documents/Death%20by%20Indifference%20-%2074%20Deaths%20and% 20counting.pdf [Accessed 06 October 2012].,Non-OADS,/arxiv_data1/oa_pdf/cb/fd/PDR-17-156.PMC4046877.pdf
"American Speech-Language-Hearing Association 2011;18:3–11, Available from: http://div14perspectives.asha.org/cgi/reprint/18/1/12.",Non-OADS,/arxiv_data1/oa_pdf/cb/fd/PDR-17-156.PMC4046877.pdf
Available from http://www.un.org/disabilities/default.asp?id=150 [Accessed 16October 2012].,Non-OADS,/arxiv_data1/oa_pdf/cb/fd/PDR-17-156.PMC4046877.pdf
The rights of children and young people in health care services in Australia.Available from http://children.wcha.asn.au/children-and-young-peoples-rights-healthcare-services-charter.,Non-OADS,/arxiv_data1/oa_pdf/cb/fd/PDR-17-156.PMC4046877.pdf
"Shane H, Blackstone S, Vanderheiden G, Williams MA, DeRuyter F. Using AAC technology to access the world.Assistive Technology: The Official Journal of RESNA.Available from http://www.resna.org/dotAsset/56975.pdf[Accessed 06 October 2012].",OADS,/arxiv_data1/oa_pdf/cb/fd/PDR-17-156.PMC4046877.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/fa/ijbsv10p0520.PMC4046879.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/d2/ijbsv10p0530.PMC4046880.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/e4/ijbsv10p0543.PMC4046881.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/8f/ijbsv10p0547.PMC4046882.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fe/10/ijbsv10p0563.PMC4046883.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203794).,OADS,/arxiv_data1/oa_pdf/0c/7d/annrheumdis-2013-203794.PMC4047212.pdf
"Pathway analysis on the basis of protein –protein interaction with Strings 9.0 software (http://string-db.org) indicateda predominant in ﬂuence of HRES-1/Rab4 on genes involved in mitochondrial outer membrane organisation (false discovery rate pvalue with Bonferrroni correction (FRD p=1.8×10 −9), membrane raft formation (p=7.5×10−9), and mTOR activation (p=9.7×10−3).",OADS,/arxiv_data1/oa_pdf/0c/7d/annrheumdis-2013-203794.PMC4047212.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ Figure 6 Effect of 3-PEHPC and Rapa relative to solvent controls PBS and CMC, respectively, on the immune system and mitochondrial homeostasis of MRL/lpr mice treated weekly between ages of 4 –14 weeks, as described under ﬁgure 5.",Non-OADS,/arxiv_data1/oa_pdf/0c/7d/annrheumdis-2013-203794.PMC4047212.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/98/78/jpts-26-629.PMC4047219.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1e/3f/jpts-26-633.PMC4047220.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a0/2f/jpts-26-637.PMC4047221.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f7/8e/jpts-26-641.PMC4047222.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ae/b6/jpts-26-645.PMC4047223.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/be/34/jpts-26-647.PMC4047224.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/53/8f/jpts-26-651.PMC4047225.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/08/48/jpts-26-655.PMC4047226.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e8/4a/jpts-26-661.PMC4047227.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d8/21/jpts-26-665.PMC4047228.pdf
http://law.go.kr/ unSc.do?menuId=7 &query=%EC%9A% 94%EC%96%91%EB%B3%B4%ED%98%B8.,Non-OADS,/arxiv_data1/oa_pdf/d8/21/jpts-26-665.PMC4047228.pdf
http://www.kosha.or.kr/www/boardView.do?menuId= 896&contentId=338223&boardType=A.,Non-OADS,/arxiv_data1/oa_pdf/d8/21/jpts-26-665.PMC4047228.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4f/36/jpts-26-671.PMC4047229.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/14/89/jpts-26-675.PMC4047230.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/55/bc/jpts-26-679.PMC4047231.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/de/f5/jpts-26-683.PMC4047232.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1a/90/jpts-26-689.PMC4047233.pdf
REFERENCES 1) http://mlb.mlb.com/usa_baseball/article.jsp?story=medsafety11.,Non-OADS,/arxiv_data1/oa_pdf/1a/90/jpts-26-689.PMC4047233.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/71/1e/jpts-26-695.PMC4047234.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/29/0e/jpts-26-701.PMC4047235.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/d5/jpts-26-707.PMC4047236.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/26/b9/jpts-26-711.PMC4047237.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/d8/e3/jpts-26-717.PMC4047238.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/39/f9/jpts-26-721.PMC4047239.pdf
"2011. http://www1.inca.gov.br/esti - mativa/2012/estimativa20122111.pdf (Accessed Aug. 8, 2012) 2) Haddad CF: Radioterapia adjuvante no câncer de mama operável.",Non-OADS,/arxiv_data1/oa_pdf/39/f9/jpts-26-721.PMC4047239.pdf
http://www.ibge.gov.br/home/geociencias/recursosnaturais/ids/ids2010.pdf (ac - cessed Apr.,Non-OADS,/arxiv_data1/oa_pdf/39/f9/jpts-26-721.PMC4047239.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3a/95/jpts-26-731.PMC4047240.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/75/d5/jpts-26-737.PMC4047241.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/b1/e7/jpts-26-741.PMC4047242.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/ea/jpts-26-745.PMC4047243.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d7/5a/jpts-26-749.PMC4047244.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a0/9d/jpts-26-753.PMC4047245.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d4/58/jpts-26-755.PMC4047246.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/81/c4/jpts-26-759.PMC4047247.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5e/ec/jpts-26-763.PMC4047248.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/99/a6/jpts-26-771.PMC4047249.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/41/51/jpts-26-777.PMC4047250.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0c/bc/jpts-26-779.PMC4047251.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/6b/68/jpts-26-783.PMC4047252.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/29/jpts-26-785.PMC4047253.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/72/39/jpts-26-789.PMC4047254.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/48/6b/jpts-26-793.PMC4047255.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.Copyright *2014 by IGCS and ESGO ISSN: 1048-891XDOI: 10.1097/IGC.0000000000000105 Copyright © 2014 by IGCS and ESGO.,Non-OADS,/arxiv_data1/oa_pdf/d9/73/igj-24-629.PMC4047297.pdf
The statistical analy-ses were performed in SPSS (version 18) and the statistical program “R” (version 2.13;  http://www.r-project.org ) using  the libraries veriﬁ  cation and gam.,OADS,/arxiv_data1/oa_pdf/e4/b8/spne-39-e455.PMC4047301.pdf
"The trial is registered at  http://www.clinicaltrials.gov ,  with registration number NCT00463970.",Non-OADS,/arxiv_data1/oa_pdf/e4/b8/spne-39-e455.PMC4047301.pdf
Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/ 217040/2012-13-reference-costs-guidance.pdf .,Non-OADS,/arxiv_data1/oa_pdf/19/5e/yic-29-229.PMC4047303.pdf
"Direct URL citations appear in the printed text, and links to the digital ﬁles are provided in the HTML text of this article on the journal’ s Web site (http://www.stdjournal.com).",Non-OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
"METHODS Data Sources The design and study procedures of the cross-sectional studies, known as integrated behavioral and biological assess- ments (IBBAs), have been described in detail elsewhere14,15and are summarized in the Supplementary Online Material Methodssection, http://links.lww.com/OLQ/A86, as are the main com-ponents of the Avahan intervention.",Non-OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
"Details on the methods used to derive these estimates are provided in the Supplementary Online Material Methods section, http://links.lww.com/OLQ/A86.",OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
"We considered a total of 53 district-level contextual variables for inclusion in the multilevel statistical model (seecomplete list in the Supplementary Online Material Table,http://links.lww.com/OLQ/A87).",OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
The study and its consent procedures were approved by the ethics committees of all institutions that were involved in thedata collection for this study (see Supplementary Online Mate-rial Methods section for more details on ethical considerations http://links.lww.com/OLQ/A86).,Non-OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
Lancet Global Health 2013. http://dx.doi.org/10.1016/S2214-109X(13)70083-4.,Non-OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
"AnnualReport 2011-122011, Available at: http://www.nacoonline.org/upload/Publication/Annual%20Report/NACO_AR_Eng%202011-12.pdf.",Non-OADS,/arxiv_data1/oa_pdf/07/90/olq-41-380.PMC4047305.pdf
"Women were then invited to participate in the study using a variety of methods thatdiffered by study site (Table 1, Supplemental Digital Content 1,http://links.lww.com/IGC/A201).",Non-OADS,/arxiv_data1/oa_pdf/95/c3/igj-24-576.PMC4047307.pdf
"We noted an important trade off in sensitivity and false positivity (1 specificity) of VIA for CIN2+ and CIN3+ by clinical site (Figure 1, Supplemental Digital Content 2, http://links.lww.com/IGC/A200).",Non-OADS,/arxiv_data1/oa_pdf/95/c3/igj-24-576.PMC4047307.pdf
"Restricted to the subset read by both pathologists, the second read was less sensitive (20.8% vs 81.8%) and slightly more specific (98.6% vs 97.2%) for CIN2+than the original study reading (Table 2, Supplemental DigitalContent 3, http://links.lww.com /IGC/A201).",Non-OADS,/arxiv_data1/oa_pdf/95/c3/igj-24-576.PMC4047307.pdf
Available at: http://globocan.iarc.fr/.,Non-OADS,/arxiv_data1/oa_pdf/95/c3/igj-24-576.PMC4047307.pdf
"15  The interview contained questions conﬁ  rming whether  the participant had RTW, whether they were currently work-ing, and various aspects of recurrence including whether they had to take additional time off work, whether they experienced pain or difﬁ  culties due to their condition, and whether they  sought health care since RTW (see Supplemental Digital Con-tent Appendix A available at http://links.lww.com/BRS/A839).",Non-OADS,/arxiv_data1/oa_pdf/d0/ac/spne-38-2279.PMC4047308.pdf
Available at: http://www.epp.,Non-OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available at: http://www.hse.gov.uk/sta- tistics/overall/hssh1011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available at: http://www.bls.gov/ news.release/pdf/osh2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available  at: http://www.safeworkaustralia.gov.au/sites/SWA/AboutSafe-WorkAustralia/WhatWeDo/Publications/Documents/661/Compen-dium%202009_10%20report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available at: http://mines.industry.qld.gov.au/assets/health-report/ mine_safety_report_10–11_full_report.pdf .,OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available at:  http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexapi!prod!CELEXnumdoc&lg=EN&numdoc=32000L0043&model=guichett”model=guichett.,Non-OADS,/arxiv_data1/oa_pdf/be/f3/spne-38-2208.PMC4047309.pdf
Available at: http://www.kay pahoito.fi [Accessed 30 August 2012].,Non-OADS,/arxiv_data1/oa_pdf/ce/3d/yic-29-216.PMC4047310.pdf
Available at: http://www.has-sante.fr .,Non-OADS,/arxiv_data1/oa_pdf/ce/3d/yic-29-216.PMC4047310.pdf
Available at: http://www.nice.org.uk/ nicemedia/live/13419/53619/53619.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ce/3d/yic-29-216.PMC4047310.pdf
Available at: http://kaken.nii.ac.jp/d/p/ 23780274.en.html .,Non-OADS,/arxiv_data1/oa_pdf/6e/08/wnr-24-988.PMC4047316.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.Copyright *2014 by IGCS and ESGO ISSN: 1048-891XDOI: 10.1097/IGC.0000000000000076 Copyright © 2014 by IGCS and ESGO.,Non-OADS,/arxiv_data1/oa_pdf/85/43/igj-24-615.PMC4047319.pdf
"All primer sequences were designed using Primer3 Input software (version 0.4.0, http://frodo.wi.mi t.edu/primer3/ ;T a b l e 1)a n d were synthesized by the DNA Sequencing and Oligonucleotyde Synthesis Lab in the Institute of Biochemistry and Biophysics PAN ( www.ibb.waw.pl ).",OADS,/arxiv_data1/oa_pdf/31/0f/11626_2013_Article_9711.PMC4047483.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e9/1f/srep05099.PMC4047528.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5099 | DOI: 10.1038/srep05099 6",Non-OADS,/arxiv_data1/oa_pdf/e9/1f/srep05099.PMC4047528.pdf
Methods Molecular structure and optimization .The 3D structure of a2u B chain (PDB code: 2a2u) was obtained from the RCSB-PDB (http://www.rcsb.org/pdb).,OADS,/arxiv_data1/oa_pdf/0b/72/srep05201.PMC4047529.pdf
The 2D structure of the farnesol was obtained from the Pubchem compound module(http://pubchem.ncbi.nlm.nih.gov/) and the compound id (CID) are 1549109 (farnesol) and 8663 (2-naphthol).,OADS,/arxiv_data1/oa_pdf/0b/72/srep05201.PMC4047529.pdf
The 2D structure of the compound was then converted into the corresponding 3D coordinates using the Babel server (http://openbabel.sf.net).,OADS,/arxiv_data1/oa_pdf/0b/72/srep05201.PMC4047529.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5201 | DOI: 10.1038/srep05201 7",Non-OADS,/arxiv_data1/oa_pdf/0b/72/srep05201.PMC4047529.pdf
"Stainingof labeled EML cells with Ki-67-eFluor450 (eBioscience, clone B56) followed theeBioscience Protocol B for Staining Intracellular Antigens for Flow Cytometry (http://www.ebioscience.com/media/pdf/best-protocols/staining-intracellular-antigens-for-flow-cytometry.pdf), utilizing the Foxp3/Transcription factor staining buffer set(eBioscience), followed by addition of 1 5100ml of 7-AAD (BioLegend) in PBS.",Non-OADS,/arxiv_data1/oa_pdf/cd/4c/srep05199.PMC4047531.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/4c/srep05199.PMC4047531.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5199 | DOI: 10.1038/srep05199 15",Non-OADS,/arxiv_data1/oa_pdf/cd/4c/srep05199.PMC4047531.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5195 | DOI: 10.1038/srep05195 8",Non-OADS,/arxiv_data1/oa_pdf/f8/93/srep05195.PMC4047532.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5204 | DOI: 10.1038/srep05204 8",Non-OADS,/arxiv_data1/oa_pdf/5a/e9/srep05204.PMC4047534.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/69/70/srep05207.PMC4047535.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5207 | DOI: 10.1038/srep05207 4",Non-OADS,/arxiv_data1/oa_pdf/69/70/srep05207.PMC4047535.pdf
"Moreover, the significantly lower frequency of the risk-conferring C allele of rs28493229 in CHB (7%) compared with Japanese in Tokyo or Americans (both are 15%), which data was obtained from 1000 Genomes (http://www.1000genomes.org/), might simply reflect the ethnic variation.",Non-OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
The diagnosis of KD was based on the 5threvised edition of the guidelines established by the Kawasaki Disease Research Committee in Japan in 2002 (http://kawasaki-disease.org/diagnostic/).,OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
"First, we extracted the ranges of the physical positions covering the 7 genes and their 2 Kb range up- and downstream from the HapMap database (http://hapmap.ncbi.",OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
"Second, we placed the position of each gene into an integrated bioinformatics tool ‘‘SNPinfo’’ 43(http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm) and retrieved a set of SNPs with possible functions.",OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
"Since a few of these SNPs, such as ITPKC rs7251246, STIM1 rs12806698, did not present in the results of Haploview, we rechecked the LD of these 32 SNPs using the online database of 1000 Genomes (http://www.1000genomes.org/),and found that several pairs of SNPs were in strong LD with each other (Supplementary Table S5 online).",OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5208 | DOI: 10.1038/srep05208 7",Non-OADS,/arxiv_data1/oa_pdf/dd/56/srep05208.PMC4047536.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/srep05202.PMC4047537.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5202 | DOI: 10.1038/srep05202 6",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/srep05202.PMC4047537.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/09/srep05206.PMC4047540.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5206 | DOI: 10.1038/srep05206 10",Non-OADS,/arxiv_data1/oa_pdf/e3/09/srep05206.PMC4047540.pdf
Available from:  http://www.eolss.net.,Non-OADS,/arxiv_data1/oa_pdf/88/19/PM-10-37.PMC4047571.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2719786/.,Non-OADS,/arxiv_data1/oa_pdf/19/ea/PM-10-135.PMC4047576.pdf
Published by Elsevier B.V.  http://dx.doi.org/10.1016/j.jebo.2013.07.009Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/10/a1/main.PMC4047610.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2014 |  83  | e50984 | Page 1 of 6Video Article Intra-lymph Node Injection of Biodegradable Polymer Particles James I. Andorko*1, Lisa H. Tostanoski*1, Eduardo Solano1, Maryam Mukhamedova1, Christopher M. Jewell1 1Fischell Department of Bioengineering, University of Maryland, College Park *These authors contributed equally Correspondence to: Christopher M. Jewell at cmjewell@umd.edu URL: http://www.jove.com/video/50984 DOI: doi:10.3791/50984 Keywords: Bioengineering, Issue 83, biomaterial, immunology, microparticle, nanoparticle, vaccine, adjuvant, lymph node, targeting, polymer Date Published: 1/2/2014 Citation: Andorko, J.I., Tostanoski, L.H., Solano, E., Mukhamedova, M., Jewell, C.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/28/jove-83-50984.PMC4047663.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50984/ Introduction The lymph nodes (LNs) are the command centers of the immune system.,Non-OADS,/arxiv_data1/oa_pdf/3a/28/jove-83-50984.PMC4047663.pdf
"28, 5-24, doi:http://dx.doi.org/10.1016/S0169-409X(97)00048-3 (1997).",Non-OADS,/arxiv_data1/oa_pdf/3a/28/jove-83-50984.PMC4047663.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2014 |  83  | e51366 | Page 1 of 6Video Article Sample Preparation for Single Virion Atomic Force Microscopy and Super- resolution Fluorescence Imaging Jeffery A Hodges1,2, Saveez Saffarian1,2 1Department of Physics & Astronomy, University of Utah 2Center for Cell and Genome, University of Utah Correspondence to: Saveez Saffarian at saffarian@physics.utah.edu URL: http://www.jove.com/video/51366 DOI: doi:10.3791/51366 Keywords: Basic Protocol, Issue 83, AFM, Super-resolution fluorescence imaging, single virion imaging, fPALM, dSTORM, PALM Date Published: 1/2/2014 Citation: Hodges, J.A., Saffarian, S. Sample Preparation for Single Virion Atomic Force Microscopy and Super-resolution Fluorescence Imaging.",Non-OADS,/arxiv_data1/oa_pdf/e9/fc/jove-83-51366.PMC4047664.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51366/ Introduction Charge based nonspecific interactions are routinely used for adhesion of virions in atomic force microscopy1,2.",Non-OADS,/arxiv_data1/oa_pdf/e9/fc/jove-83-51366.PMC4047664.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 99–107HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  99CASe RePo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/HIV.S6212 1Physiotherapy intervention as a complementary  treatment for people living with HIV/AIDS Sara D Pullen1 Nnenna Nina Chigbo2 emmanuel Chukwudi  Nwigwe2 Chinwe J Chukwuka3 Christopher Chim Amah4 Stanley C Idu2 1Department of Rehabilitation  Medicine, Division of Physical   therapy, emory University,    Atlanta, GA, USA;  2Department   of Physiotherapy,  3Department   of Medicine,  4Paediatric Surgery   Division, Department of Surgery,    College of Medicine, University of   Nigeria teaching Hospital, enugu,    Nigeria Correspondence: Sara D Pullen   emory University School of Medicine,   Division of Physical therapy,   Department of Rehabilitation Medicine,   1462 Clifton Road, Ne, Suite  312,   Atlanta, GA  30322, USA   tel +1 404 712 5112  Fax +1 404 712 4130  email sara.pullen@emory.ed uBackground:  The advent of highly active antiretroviral therapy has dramatically extended the life  expectancy of people living with human immunodeficiency virus (HIV)/acquired immunodefi - ciency syndrome.",Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
Available  from: http://aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/ understand-your-test-results/cd4-count /.,Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
Available from:  http://www.cdc.gov/hiv/basics/whatishiv.html .,Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
Available from: http://hab.hrsa.gov/deliverhivaidscare/ clinicalguide11/cg-00-00.html .,Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/59/hiv-6-099.PMC4047833.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/ab/dddt-8-621.PMC4047834.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 621–625Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  621Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S61045is increasing the dose of entecavir effective   in partial virological responders?",Non-OADS,/arxiv_data1/oa_pdf/2d/ab/dddt-8-621.PMC4047834.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2d/ab/dddt-8-621.PMC4047834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/ab/dddt-8-621.PMC4047834.pdf
Available from: http://www.natap.,Non-OADS,/arxiv_data1/oa_pdf/2d/ab/dddt-8-621.PMC4047834.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/4a/dddt-8-667.PMC4047835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 667–675Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  667Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6197 7Progress of clinical research on targeted   therapy combined with thoracic radiotherapy   for non-small-cell lung cancer Hongqing Zhuang1,* Xianzhi Zhao1,* Lujun Zhao1 Joe Y Chang2 Ping wang1 1Department of Radiotherapy,    Tianjin Medical University Cancer   institute and Hospital, National  Clinical Research Center for Cancer,   Tianjin Key Laboratory of Cancer  Prevention and Therapy, and Tianjin  Lung Cancer Center, Tianjin, People’s  Republic of China; 2Department  of Radiation Oncology, Division of  Radiation Oncology, The University   of Texas MD Anderson Cancer   Center, Houston, TX, USA *These authors contributed equally   to this paper Correspondence: Hongqing Zhuang;   Ping wang   Department of Radiotherapy,   Tianjin Medical University Cancer   institute and Hospital, Tianjin, 300060,   People’s Republic of China   Tel +86 22 2334 1405   Fax +86 22 2334 1405   email hongqingzhuang@163.co m;   ping_wang999@163.co mAbstract:  The combination of radiotherapy and targeted therapy is an important approach in the  application of targeted therapy in clinical practice, and represents an important opportunity for the  development of radiotherapy itself.",Non-OADS,/arxiv_data1/oa_pdf/b9/4a/dddt-8-667.PMC4047835.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b9/4a/dddt-8-667.PMC4047835.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/4a/dddt-8-667.PMC4047835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/1a/dddt-8-651.PMC4047837.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 651–666Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  651Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6044 4evaluation of ceftiofur–PhBV microparticles   in rats cristian Vilos1,3 luis constandil2,3 Paula i rodas1,3 Mario cantin4,5 Katherine Zepeda1 natalia herrera1 luis a Velasquez1,3 1center for integrative Medicine  and innovative science (ciM is),   Faculty of Medicine, Universidad  andres Bello, santiago,  2laboratory of  neurobiology, Department of Biology,   Faculty of chemistry and Biology,   Universidad de santiago de chile,   santiago,  3centro para el Desarrollo  de la nanociencia y nanotecnología,   Universidad de santiago de chile,   ecuador, santiago,  4ciMa, Department  of integral Dentistry, Faculty of  Dentistry, Universidad de la Frontera,   T emuco,  5center of research in  Biomedical sciences, Universidad  autónoma de chile, T emuco, chile correspondence: cristian Vilos   center for integrative Medicine and   innovative science (ciMis), Facultad  de Medicina, Universidad andres Bello,  echaurren  183, 8370071, santiago, chile   email cristian.vilos@unab.c lAbstract:  Despite the high number of antibiotics used for the treatment of infectious disease in  animals, the development of slow release formulations presents a significant challenge, particu - larly in using novel biomaterials with low cost.",Non-OADS,/arxiv_data1/oa_pdf/a3/1a/dddt-8-651.PMC4047837.pdf
Tokyo: Springer;  2008:  http://dx.doi.org/10.1007/978-4-431-78847- 8.,Non-OADS,/arxiv_data1/oa_pdf/a3/1a/dddt-8-651.PMC4047837.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a3/1a/dddt-8-651.PMC4047837.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/1a/dddt-8-651.PMC4047837.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.10.001qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d1/85/main.PMC4047853.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ICSBP promotes EMT-like phenomena, cell motility, and invasion JY Sung et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/46/d8/cddis2014189a.PMC4047854.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/p38/JNK sensitizes TP53-mutated cells to apoptosis M Farhat et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4a/4e/cddis2014150a.PMC4047855.pdf
The NLS was searched using cNLS mapper (http://nls-mapper.iab.,OADS,/arxiv_data1/oa_pdf/31/9f/cddis2014176a.PMC4047856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)p53 promotes PALMD to induce apoptosis N Dashzeveg et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/31/9f/cddis2014176a.PMC4047856.pdf
"The limma package(R; http://www.r-project.org/ and Bioconductor; http://www.bioconductor.org/)was used to identify differentially expressed genes, with untreated cells set ascontrol group.",OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
RNAseq computational analysis : Illumina reads were converted to the industry standard FASTQ format and aligned to the Human GRCh37 Ensembl 70reference genome using the STAR program on default settings (http://www.ncbi.nlm.nih.gov/pubmed/23104886).,OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
The SAM output from the STAR aligner was converted to BAMformat using the Picard tools suite (http://picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
"For geneexpression estimation and differential expression analysis, the programs Cufﬂinksand Cuffdiff version 2.0.2 were used with the following options ‘-u –max-bundle-frags 1000000 –no-effective-length-correction –compatible-hits-norm’ (http://www.ncbi.nlm.nih.gov/pubmed/23222703).",OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
The quality of the RNAseq experimentswas veriﬁed with RNASeQC version 1.17 (http://www.ncbi.nlm.nih.gov/pubmed/22539670).,OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
Pre-processed data from Cuffdiff 2.0.2 were further analyzed withCummeRbund 2.0.0 (http://compbio.mit.edu/cummeRbund/).,OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
"To identify individual GOs for the altered genes of the transcriptomics studies, we entered the gene names into the query ofgProﬁler (http://biit.cs.ut.ee/gproﬁler).",OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
The wordclouds were produced onhttp://www.wordle.net/advanced.,OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
The experimental metabolomics measure-ment technique is described in detail by patent US 2007/0004044 (accessibleonline at http://www.freepatentsonline.com/y2007/0004044.html).,Non-OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Neurotoxicity upstream response AK Krug et al 15 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/48/9f/cddis2014166a.PMC4047858.pdf
"By using the TFsearch applet(http://www.cbrc.jp/research/db/TFSEARCH.html), a potent AR-binding motif (5 0-CCGCTGTCC-30) was predicted to be located in the region of /C01000 to /C0360 bp.",OADS,/arxiv_data1/oa_pdf/35/36/cddis2014106a.PMC4047860.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)The prodrugs PF-CEBPD and PF-granzyme B C-H Chuang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/35/36/cddis2014106a.PMC4047860.pdf
The microarray datasets were downloaded from the database of Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/).,OADS,/arxiv_data1/oa_pdf/22/aa/cddis2014207a.PMC4047861.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/miR-26a regulates EMT in IPF H Liang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/22/aa/cddis2014207a.PMC4047861.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Cell death in ex vivo crypt organoids T Grabinger et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8a/c4/cddis2014183a.PMC4047863.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)DAPK1 regulates tau accumulation through inhibition of Pin1 BM Kim et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8a/e0/cddis2014216a.PMC4047864.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PARG in retinal degeneration A Sahaboglu et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/60/76/cddis2014208a.PMC4047865.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Estradiol enhances glucose utilization via Akt Y Sun et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/46/72/cddis2014204a.PMC4047866.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Tip30 regulates mammary luminal progenitor fate F Chen et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/84/cddis2014224a.PMC4047867.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/Mechanism of M2- to M1-M Udifferentiation by Nef M Hashimoto et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2f/f3/cddis2014233a.PMC4047869.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Rapamycin reverses insulin resistance OV Leontieva et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5d/07/cddis2014178a.PMC4047870.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Elf3 transactivates b-catenin J-L Wang et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/59/0e/cddis2014206a.PMC4047871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PEDF and low-dose chemotherapy in prostate cancer T Nelius et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/61/a8/cddis2014180a.PMC4047872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/SO2inhibits VSMC proliferation D Liu et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/29/77/cddis2014229a.PMC4047873.pdf
"As RECQL4 is reported to be highly expressed in bone marrow(http://www.genecards.org/cgi-bin/carddisp.pl?gene=RECQL4), the phenotype of bone marrow cells was further examined intwo 4-month-old male Recql4 HDand two matched wild-type mice.",Non-OADS,/arxiv_data1/oa_pdf/4b/25/cddis2014168a.PMC4047874.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)RECQL4 prevents senescence in human cells and mice HL u et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4b/25/cddis2014168a.PMC4047874.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Role of ghrelin in testicular radiation injury WL i et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/94/cddis2014223a.PMC4047875.pdf
The structure of clomipramine was downloaded from the GPCR Ligand Library60(http://cavasotto-lab.net/Databases/GDD/).,OADS,/arxiv_data1/oa_pdf/61/97/cddis2014113a.PMC4047876.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HECT E3 ligase ITCH inhibitors M Rossi et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/61/97/cddis2014113a.PMC4047876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Metformin and a-synuclein BI Pe´rez-Revuelta et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b3/06/cddis2014175a.PMC4047877.pdf
TheCREAM is freely available at http://bioinfo.hrbmu.edu.,OADS,/arxiv_data1/oa_pdf/74/f2/cddis2014236a.PMC4047878.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/74/f2/cddis2014236a.PMC4047878.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Editorial 3 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b4/be/cddis2014195a.PMC4047879.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/Bioactive lipids and pro-apoptotic activity V Mignard et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/67/e7/cddis2014226a.PMC4047880.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Systems biology of death receptor networks IN Lavrik 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f2/9e/cddis2014160a.PMC4047881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Rasfonin induces ras-mutated pancreatic tumor death Z Xiao et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2e/bc/cddis2014213a.PMC4047882.pdf
The pictures were further processed by using the Image J software(http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/40/1f/cddis2014231a.PMC4047883.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CHK1 suppresses Aurora B activation P Zuazua-Villar et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/40/1f/cddis2014231a.PMC4047883.pdf
"The areaof ONL was also measured by Image J software (developed by Wayne Rasband,National Institutes of Health, Bethesda, MD, USA; available at http://rsb.info.nih.gov/ij/index.html), and then TUNEL-positive cell density in ONL was calculated.",OADS,/arxiv_data1/oa_pdf/8b/02/cddis2014218a.PMC4047884.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MST2 not MST1 mediates RD-induced photoreceptor cell death H Matsumoto et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8b/02/cddis2014218a.PMC4047884.pdf
"NOTCH, WNT, AD, and apoptosis subnetwork models were developed through (i) extracting theinformation provided by the KEGG PATHWAY database (http://www.genome.jp/kegg/pathway.html; NOTCH pathway: map04330, WNT pathway: map 04310;AD pathway: map05010, and apoptosis pathway: map04210); and (ii) byestablishing the interactions between genes/proteins with the database resource Search Tool for the Retrieval of Interacting Genes/Proteins STRING version 9.05 (http://string-db.org/); with ‘Experiments’ and ‘Databases’ as input options and aconﬁdence score of 0.600.",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
The Venn diagram wasconstructed by using the freely available software system R (http://www.r-project.org) 67in order to visualize the grade of molecular relation (common genes/proteins) between the generated subnetworks.,OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"The in silico network model integrating NOTCH, WNT, AD, and apoptosis subnetworks (NOWADA) wasdeveloped by using again STRING version 9.05 with ‘Experiments’ and‘Databases’ as input options and a conﬁdence score of 0.600 (0.400 is considered‘medium conﬁdence’) and plotted by using Cytoscape, an open source platform forcomplex network analysis and visualization (http://www.cytoscape.org/).",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
Geo DataSets database (http://www.ncbi.nlm.nih.gov/geo/).,OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"The information from the different pathways (NOTCH, WNT, AD, and apoptosis) was gathered from KEGG pathway (http://www.genome.jp/kegg/pathway.html) to develop the subnetworks.",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
Centrality values were plotted in graphs by using OriginLab (http://www.originlab.com/index.aspx?go=Products/OriginPro).,OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"To construct the compound (drug)-gene/protein network models, we ﬁrst performed a systematic review of relevant literature associatedwith autism or AD therapy in the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/).",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"Moreover, compoundidentiﬁer, formula, description, and selected autism- and AD-related reports (withPMID) for these drugs (Supplementary Table S6) are additionally provided withKEGG DRUG (http://www.genome.jp/kegg/drug/), the Search Tool for Interactionsof Chemicals STITCH version 3.1 (http://stitch.embl.de/), and PubMed databaseas sources of information.",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"To achieve this goal, STITCH version 3.1 (http://stitch.embl.de/) was used with ‘Experiments’ and ‘Databases’ as input options anda conﬁdence score of 0.600 (0.400 is considered ‘medium conﬁdence’).A list with the most drug-targeted network nodes (genes/proteins) is alsoprovided (Supplementary Table S8).",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"The biological processes of the genes products belonging to the subnetwork modelof interactions was determined by using the database for annotation,visualization, and integrated discovery DAVID v6.7 (http://david.abcc.ncifcrf.gov/), giving a number of functional annotation tools to researchers for bettercomprehension of the biological meaning behind any large list of genes.",OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"The images or other third partymaterial in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Alzheimer’s disease-related genes in autism F Zeida ´n-Chulia ´et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/25/0a/cddis2014227a.PMC4047885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Systems biology of cell-to-cell variability X Xia et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d6/be/cddis2014199a.PMC4047886.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/Purkinje cells link to T2D complications S Yang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/bf/1e/cddis2014184a.PMC4047887.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Post-caspase activation inhibition of apoptosis K Mnich et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/cddis2014173a.PMC4047888.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)The neurogenic role of CSB F Ciaffardini et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ff/a7/cddis2014228a.PMC4047889.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/OPN and liver ischemia–reperfusion S Patouraux et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/72/96/cddis2014174a.PMC4047890.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/b-Lapachone induces programmed necrosis EJ Park et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/da/1d/cddis2014202a.PMC4047891.pdf
"The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need toobtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CT20 peptide causes death of metastatic cells MW Lee et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/53/c8/cddis2014225a.PMC4047892.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Systems biology of lung cancer therapy K Viktorsson et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/39/c7/cddis201428a.PMC4047893.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Table 1 Oligonucleotides used in this study Name Primer (50-30) Restriction sites Construct Application CD40EcoR-F GAATTCAAAAAGGTGGCCAAGAAG EcoR1 pEG202/CD40 Yeast two hybrid CD40Xho-R CTCGAGTCACTGTCTCTCCTGC Xho1 pEG202/CD40 Yeast two hybrid FAFXho-F1 CTCGAGTGGCGTCCAACATGGA C Xho1 pEGFPC1/FAF1wt&mt Protein expression FAFEcoR-R915 CTTAAGTTAATCCACCCCAAATTCTGTAG C EcoR1 pEGFPC1/FAF1mt Protein expression FAFEcoR-R1953 CTTAAGTTACTCTTTTGCTTCAAGGAAAAGG EcoR1 pEGFPC1/FAF1wt Protein expression GAPDHF244 CCTCCAAAATCAAGTGGGGCG NA NA RT-PCR GAPDHR845 ACCACCAGGTGCTCAGTGTAG NA NA RT-PCR FAF1F GCCACCAAT TATGGGAGG G NA NA RT-PCRFAF1R CAG ATC CCA AGC CCA GGT NA NA RT-PCRFas-associated factor (Faf1) is a novel CD40 interactor T Elmetwali et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b9/27/cddis2014172a.PMC4047894.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Orchestration of autophagy by sphingolipids YL i et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2a/82/cddis2014215a.PMC4047895.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HSCARG and USP7 inhibit NEMO ubiquitination TL i et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a4/7b/cddis2014197a.PMC4047896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)FoxO mediates APP-induced cell death X Wang et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a5/5b/cddis2014196a.PMC4047897.pdf
"The recent characterization of the human cancer genome (Cancer Genome Atlas Research Network, 2008;http://cancergenome.nih.gov/)12and transcriptome13,14of GBM has provided a high-resolution picture that has revealedthe major gene alterations that may drive disease pathogen- esis and biology.",OADS,/arxiv_data1/oa_pdf/dd/68/cddis2014188a.PMC4047898.pdf
"In particular, UCN-01 targets PDK1, PKC, and CHK1 (UCN-01/Staurosporine KinomeInteraction heatmaps are available at SuperNova LifeScience, http://www.supernovalifescience.com).",Non-OADS,/arxiv_data1/oa_pdf/dd/68/cddis2014188a.PMC4047898.pdf
"Quantiﬁcation of the bands was performed by using ImageJ v1.47 (National Institutes of Health,Bethesda, MD, USA, http://imagej.nih.gov/ij/) and intensities of the bands for eachantibody tested were normalized over their correspondent actin.",OADS,/arxiv_data1/oa_pdf/dd/68/cddis2014188a.PMC4047898.pdf
"R Foundation for Statistical Computing: Vienna, Austria, 2013. http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/dd/68/cddis2014188a.PMC4047898.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Targeting of PDK1 and CHK1 in glioblastoma M Signore et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/dd/68/cddis2014188a.PMC4047898.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HKH40A downregulates GRP78/BiP T Kosakowska-Cholody et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/2b/15/cddis2014203a.PMC4047900.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Celastrol in human glioblastoma cells S Boridy et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/20/22/cddis2014182a.PMC4047902.pdf
54–56All constructs were veriﬁed by nucleic acid sequencing; subsequent analysis was performed using BLAST software (available at http://www.ncbi.nlm.nih.gov/blast/).,OADS,/arxiv_data1/oa_pdf/22/62/cddis2014194a.PMC4047903.pdf
"The GEP-knockout (GEP /C0//C0) mice were bought from Jackson Laboratories (Bar Harbor, ME, USA); the generation and genotypingof GEP /C0//C0mice on the basis of Jackson Laboratory’s protocol were used for these experiments (http://jaxmice.jax.org/query/).",Non-OADS,/arxiv_data1/oa_pdf/22/62/cddis2014194a.PMC4047903.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/IRE1a regulates osteogenic differentiation F-J Guo et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/22/62/cddis2014194a.PMC4047903.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/New advancements in induced pluripotent stem cells K Liu et al 6 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c1/61/cddis2014205a.PMC4047905.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Axl-altered microRNAs in lung cancer Y Wang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/01/ef/cddis2014186a.PMC4047906.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)The coagulation cascade modulates autophagy of HCC K-D Chen et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7f/fd/cddis2014212a.PMC4047908.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/FoxM1 delivery to hepatocytes enhances liver repopulation D Xiang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5c/68/cddis2014230a.PMC4047909.pdf
"The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need toobtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Radiation induces metabolic alterations E-C Liao et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d3/29/cddis2014220a.PMC4047910.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PERK/eIF2 a/ATF4 axis in selenite-treated NB4 cells Q Jiang et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0d/9a/cddis2014200a.PMC4047911.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Systematic approaches to tackle CDDP resistance L Galluzzi et al 18 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/66/bc/cddis2013428a.PMC4047912.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/Zeaxanthin activates phase II enzymes X Zou et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/61/bf/cddis2014190a.PMC4047913.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Prolidase binds and modulates ErbB2 L Yang et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/00/1e/cddis2014187a.PMC4047914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)ROS regulates apoptosis and glucose metabolism D Dixit et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/01/02/cddis2014179a.PMC4047915.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/RIP-kinases modulate noise-induced OHC death H-W Zheng et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f3/43/cddis2014177a.PMC4047918.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Alpha-synuclein in T-lymphocyte autophagy T Colasanti et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c1/18/cddis2014211a.PMC4047919.pdf
"Blots were analyzed with ImageJsoftware (open freeware provided by the NIH, Bethesda, MD, USA; http://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/51/85/cddis2014191a.PMC4047920.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ROCK2 regulates cell death and regeneration JC Koch et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/51/85/cddis2014191a.PMC4047920.pdf
"The images or other third party material in this article are included in the article’s Creative Commonslicense, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)WIF1 reduces cancer stemness I Ramachandran et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/41/02/cddis2014219a.PMC4047921.pdf
"Toview a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Cab45S inhibits ER stress-induced apoptosis L Chen et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/81/94/cddis2014193a.PMC4047922.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/From apoptosis systems biology to systems medicine ML Wu ¨rstle et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/5d/c5/cddis201436a.PMC4047923.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Quantitative evaluation of centrosome declustering drugs A Ogden et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fd/4b/cddis2014164a.PMC4047924.pdf
"15,04318 Leipzig, Germany;3Institute forBiochemistry andBiology, University ofPotsdam, Maulbeerallee, 214469 Potsdam, Germany;4German Centre forIntegrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Deutscher Platz 5e,04103 Leipzig, Germany *Corresponding author: Donald L.DeAngelis (ddeangelis@bio.miami.edu) F1000Prime Reports 2014, 6:39(doi:10.12703/P6-39) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/39 Abstract Individual-based models simulate populations and communities byfollowing individuals and their properties.,Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Page 2of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:39 http://f1000.com/prime/reports/b/6/39",Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Unlike differential equation models, inwhich theoutcomes arepredestined bythe assumptions made intheequations, Gecko produced Page 3of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:39 http://f1000.com/prime/reports/b/6/39",OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Page 4of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:39 http://f1000.com/prime/reports/b/6/39",Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:39 http://f1000.com/prime/reports/b/6/39",Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
[http://ccl.northwestern.edu/netlogo/] 65.,Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:39 http://f1000.com/prime/reports/b/6/39",Non-OADS,/arxiv_data1/oa_pdf/5c/50/biolrep-06-39.PMC4047944.pdf
"Advances in the management of squamous cell carcinoma of the head and neck Jean-Pascal Machiels*, Maarten Lambrecht, François-Xavier Hanin, Thierry Duprez, Vincent Gregoire, Sandra Schmitz and Marc Hamoir Address: Clinique de cancérologie cervico-maxillo-faciale, Centre du cancer et d ’hématologie, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (IREC), Université catholique de Louvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium * Corresponding author: Jean-Pascal Machiels (jean-pascal.machiels@uclouvain.be) F1000Prime Reports 2014, 6:44 (doi:10.12703/P6-44) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/44 Abstract Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide.,Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"The role of IMRT in reducing other toxicities such as late dysphagia is Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
[http://globoscan.iarc.fr] 2.,Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Chung CH, ElyK,McGavran L,Varella-Garcia M,Parker J,Parker N, Jarrett C,Carter J,Murphy BA, Netterville J,Burkey BB,Sinard R, Cmelak A,Levy S,Yarbrough WG, Slebos RJ,Hirsch FR:Increased Page 6of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
[http://oralcancerfoundation.org/treatment/pdf/ head-and-neck.pdf] 41.,Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
[http://www.snm.org/docs/PET_PROS/ OncologyPracticeGuidelineSummary.pdf] 42.,Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A: Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:44 http://f1000.com/prime/reports/m/6/44",Non-OADS,/arxiv_data1/oa_pdf/19/0a/medrep-06-44.PMC4047945.pdf
"Advances in treating glioblastoma Shiao-Pei Weathers and Mark R. Gilbert* Address: Department of Neuro-Oncology, University of Texas MD Ande rson Cancer Center, 1515 Holcombe Blvd., Unit 431 , Houston, TX 77030, USA * Corresponding author: Mark R. Gilbert (mrgilbert@mdanderson.org) F1000Prime Reports 2014, 6:46 (doi:10.12703/P6-46) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/46 Abstract Glioblastoma is the most common and most aggressive primary brain tumor in adults.,Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Protein kinase B (AKT) Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Theprimary endpoint of prolonging progression freesurvival wasnotreachedTable 1.Actionable molecular targets inglioblastoma Molecular Targets inGlioblastoma Cell Surface Growth Factor Receptors Epidermal growth factor receptor (EGFR) Platelet derived growth factor receptor (PDGFR) Vascular endothelial growth factor (VEGF) Transforming growth factor receptor (TGFR) Fibroblast growth factor receptor (FGFR) Receptor Tyrosine Kinase Signaling andDownstream Effectors Ras/Mitogen-activated Protein Kinase (MAPK) PI3-Kinase/Akt Mammalian target ofrapamycin (mTOR) Protein kinase C TP53 Rb(retinoblastoma) signaling Angiogenesis Inhibition Vascular endothelial growth factor receptor (VEGFR) VEGF Other Targets Histone deacetylase (HDAC) IDH1/2 mutations Page 4of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Page 5of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Interpretation of the MRI becomes even more paramount, particularly in the absence of any clinical Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"V e r h a a kR o e lG W ,H o a d l e yK A ,P u r d o mE ,W a n gV ,Q iY , Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O ’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:46 http://f1000.com/prime/reports/m/6/46",Non-OADS,/arxiv_data1/oa_pdf/e9/15/medrep-06-46.PMC4047946.pdf
"Advances inthemanagement ofinsomnia Wilfred R.Pigeon1,2,3*,Todd M.Bishop2,5andJonathan A.Marcus4 Addresses:1Center ofExcellence forSuicide Prevention, Canandaigua VAMedical Center, 400Fort HillAvenue, Canandaigua, NY14424, USA; 2Center forIntegrated Healthcare, 800Irving Avenue, Syracuse, NY13210, USA;3Department ofPsychiatry and;4Department ofNeurology , University ofRochester Medical Center, Rochester, NY14642, USA;5Department ofPsychology, 430 Huntington Hall, Syracuse University, Syracuse *Corresponding author: Wilfred R.Pigeon (Wilfred_Pigeon@URMC.Rochester.edu) F1000Prime Reports 2014, 6:48(doi:10.12703/P6-48) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/48 Abstract Insomnia ishighly prevalent andassociated with considerable morbidity.,Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Relaxation training [46] alonehas been shown to improve several features of insomnia.Sleep restriction therapy [47], which limits the patient ‘s time in bed to the amount of time they report sleeping, Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"This work alsoshows that sleep improvements associated with the Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T: Efficacy and safety of doxepin 3 and 6 mg in Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
[http://www1.actelion.com/en/our-company/news- and-events/index.page?newsId=1483135] 66.,Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:48 http://f1000.com/prime/reports/m/6/48",Non-OADS,/arxiv_data1/oa_pdf/87/95/medrep-06-48.PMC4047947.pdf
"Osterhaus (a.osterhaus@erasmusmc.nl) F1000Prime Reports 2014, 6:47 (doi:10.12703/P6-47) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/47 Abstract Influenza virus infections yearly cause high morbidity and mortality burdens in humans, and the development of a new influenza pandemic continues to threaten mankind as a Damoclean sword.Influenza vaccines have been produced by using egg-based virus growth and passaging techniques thatwere developed more than 60 years ago, following the identification of influenza A virus as anetiological agent of seasonal influenza.",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Cellular immune Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"In addition, a range of T cell-based vaccines have been developed and tested in both animal models and phase I Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
[http://www.who.int/mediacentre/ factsheets/fs211/en/] 2.,Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Page 6of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Chen GL, Lau Y, Lamirande EW, McCall AW, Subbarao K: Seasonal influenza infection and live vaccine prime for a response to Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
[http://www.cdc.gov/flu/ protect/vaccine/qa_flublok-vaccine.htm] 47.,Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:47 http://f1000.com/prime/reports/m/6/47",Non-OADS,/arxiv_data1/oa_pdf/c3/73/medrep-06-47.PMC4047948.pdf
"Management ofthrombocytopenia Marina Izak1,2*andJames B.Bussel1 Addresses:1NYPresbyterian Hospital andWeill Cornell Medical College, Division ofPediatric Hematology Oncology, 525East68th Street, Payson Pavilion 695, New York, NY10065, USA;2Assaf Harofeh Medical Center, Beer Yakov, Zerifin 70300, Israel *Corresponding author: Marina Izak (mai2013@med.cornell.edu) F1000Prime Reports 2014, 6:45(doi:10.12703/P6-45) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/m/6/45 Abstract Thrombocytopenia isoneofthemost common hematologic disorders, characterized byanabnormally low number ofplatelets from multiple causes.",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Page 2of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Page 3of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Appearance ofdacrocytes (“teardrop ”erythrocytes) and nucleated erythrocytes should lead tofurther bone Page 4of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"According to the AmericanSociety of Hematology 2011 guidelines, treatment initia-tion is suggested when an adult patient is newly-diagnosed with a platelet count <30 ×10 9/L (grade 2C evidence) [19], Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Other supportive measures include high dose intravenous Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Splenectomy can be performed during the second trimester for severe ITP cases but this Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
[http://www.medscape.com/] 13.,Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A: Safety and efficacy of eltrombopag for treatment Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:45 http://f1000.com/prime/reports/m/6/45",Non-OADS,/arxiv_data1/oa_pdf/9d/a1/medrep-06-45.PMC4047949.pdf
"Management of pediatric uveitis Bailey A. Wentworth1,2, Clovis A. Freitas-Neto1,2and C. Stephen Foster1,2,3* Addresses:1Massachusetts Eye Research and Surgery Institution (MERSI), 5 Cambridge Center, Cambridge, MA 02142, USA;2Ocular Immunology and Uveitis Foundation, 348 Glen Road, Weston, MA 02493, USA;3Department of Ophthalmology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA * Corresponding author: C. Stephen Foster (sfoster@mersi.com) F1000Prime Reports 2014, 6:41 (doi:10.12703/P6-41) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/41 Abstract Pediatric uveitis is a topic of special interest not only because of the unique diagnostic and therapeutic challenges but also because of the lifetime burden of vision loss if the problem is not adequatelytreated, as well as the economic and psychological toll on the family.",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"As topical steroids are generallyineffective at penetrating the eyeball to the posteriorsegment, systemic treatment or regional injections may be Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"In our retrospective medical recordreview of 20 pediatric patients (28 eyes) who underwentpars plana vitrectomy, quiescence of uveitis was achieved at last follow-up, with or without adjuvant therapy, in Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Jabs DA, Nussenblatt RB,Rosenbaum JT;Standardization ofUveitis Nomenclature (SUN) Working Group: Standardization ofuveitis Page 6of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Pujari SS,Kempen JH,Newcomb CW, Gangaputra S,Daniel E,Suhler EB, Thorne JE,Jabs DA, Levy-Clarke GA, Nussenblatt RB,Rosenbaum JT, Page 7of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:41 http://f1000.com/prime/reports/m/6/41",Non-OADS,/arxiv_data1/oa_pdf/30/6d/medrep-06-41.PMC4047950.pdf
"Developments in HIV-1 immunotherapy and therapeutic vaccination Peter Lawrence Smith*, Helen Tanner and Angus Dalgleish Address: St George ’s, University of London, Institute for Infection and Immunity, 1 Cranmer Terrace, London SW17 0RE, UK * Corresponding author: Peter Lawrence Smith (plsmith@sgul.ac.uk) F1000Prime Reports 2014, 6:43 (doi:10.12703/P6-43) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/43 Abstract Since the human immunodeficiency virus (HIV-1) pandemic began, few prophylactic vaccines have reached phase III trials.",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"In vitro experiments using cells from healthy and HIV-1-infected individualsshowed that CTLA4 is upregulated in the CD4 +T cells Page 2 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Page 3 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Antibody-depende nt cellular cytotoxicity Page 4 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Page 5 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Inaphase IItrial ofuntreated, otherwise-healthy, HIV-1-infected adults, significant Page 6of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Page 7 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Page 8 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Brenchley JM,Schacker TW, Ruff LE,Price DA, Taylor JH,Beilman GJ, Nguyen PL,Khoruts A,Larson M,Haase AT,Douek DC:CD4+ Tcell Page 9of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Rueda CM, Velilla PA, Chougnet CA, Montoya CJ, Rugeles MT: HIV- induced T-cell activation/exhaustion in rectal mucosa is Page 10 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"García F, Climent N, Guardo AC, Gil C, León A, Autran B, Lifson JD, Martínez-Picado J, Dalmau J, Clotet B, Gatell JM, Plana M, Gallart T; DCV2/MANON07-ORVACS Study Group: A dendritic cell-based Page 11 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Page 12of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:43 http://f1000.com/prime/reports/m/6/43",Non-OADS,/arxiv_data1/oa_pdf/b9/28/medrep-06-43.PMC4047951.pdf
"Advances in managing type 2 diabetes: challenging old paradigms and developing new ones Naveed Sattar Address: Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Avenue, Glasgow, G12 8TA, UK Email: naveed.sattar@glasgow.ac.uk F1000Prime Reports 2014, 6:42 (doi:10.12703/P6-42) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/42 Abstract As is well known, diabetes rates continue to escalate worldwide, adding cost and disease burden to all health-care institutions.",Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
"Page 2 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:42 http://f1000.com/prime/reports/m/6/42",Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
2010 Scottish Intercollegiate Guidelines Networ k [http://www.sign.ac.uk/pdf/ sign116.pdf] 4.,Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes Page 3 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:42 http://f1000.com/prime/reports/m/6/42",Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
"Page 4 of 4 (page number not for citation purposes)F1000Prime Reports 2014, 6:42 http://f1000.com/prime/reports/m/6/42",Non-OADS,/arxiv_data1/oa_pdf/f5/15/medrep-06-42.PMC4047952.pdf
"Chronic thromboembolic pulmonary hypertension: time for research inpathophysiology tocatch upwith developments intreatment Mark Toshner *andJoanna Pepke-Zaba* Address: Papworth Hospital, Papworth Everard, Cambridge, CB23 3RE, UK Corresponding author: Joanna Pepke-Zaba (joanna.pepkezaba@papworth.nhs.uk) F1000Prime Reports 2014, 6:38(doi:10.12703/P6-38) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/m/6/38 Abstract The modern treatment erainchronic thromboembolic disease hasseen significant advances inboth surgical andmedical treatment.,Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"There is some debate about whether these Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:38 http://f1000.com/prime/reports/m/6/38",Non-OADS,/arxiv_data1/oa_pdf/c4/7c/medrep-06-38.PMC4047953.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50731 | Page 1 of 8Video Article Seeded Synthesis of CdSe/CdS Rod and Tetrapod Nanocrystals Karthish Manthiram*1,4, Brandon J. Beberwyck*2,4, Dmitri V. Talapin5,6, A. Paul Alivisatos2,3,4 1Department of Chemical Engineering, UC Berkeley 2Department of Materials Science and Engineering, UC Berkeley 3Department of Chemistry, UC Berkeley 4Materials Sciences Division, Lawrence Berkeley National Laboratory 5Department of Chemistry, University of Chicago 6Center for Nanoscale Materials, Argonne National Laboratory *These authors contributed equally Correspondence to: A. Paul Alivisatos at alivis@berkeley.edu URL: http://www.jove.com/video/50731 DOI: doi:10.3791/50731 Keywords: Chemistry, Issue 82, nanostructures, synthesis, nanocrystals, seeded rods, tetrapods, nanoheterostructures Date Published: 12/11/2013 Citation: Manthiram, K., Beberwyck, B.J., Talapin, D.V., Alivisatos, A.P.",Non-OADS,/arxiv_data1/oa_pdf/9e/0c/jove-82-50731.PMC4047954.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50731/ Introduction The synthesis of multicomponent nanostructures has developed rapidly over recent years1.,Non-OADS,/arxiv_data1/oa_pdf/9e/0c/jove-82-50731.PMC4047954.pdf
"http://dx.doi.org/10.1016/j.ijppaw.2013.10.003qThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/61/fc/main.PMC4047958.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 145–152Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  145RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3918 5Importance of antimicrobial stewardship   to the english National Health Service Jill Dixon Christopher JA Duncan Department of Infectious Diseases  and Tropical Medicine, Royal victoria  Infirmary, Queen victoria Road,   Newcastle upon Tyne, UK Correspondence: Christopher JA Duncan   Department of Infectious Diseases  and Tropical Medicine, Royal victoria  Infirmary, Queen Victoria Road,  Newcastle upon Tyne, Ne1 4LP, UK   Tel +44 019 1233 6161 extension 23710   email chrisduncan@doctors.net.u kAbstract : Antimicrobials are an extremely valuable resource across the spectrum of modern  medicine.",Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
"Available  from:  https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/   244058/20130902_UK_5_year_AMR_strategy.pd f.23 Abbreviation:  AMR, antimicrobial resistance.",OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
Available  from: https://www.gov.uk/government/publications/chief-medical- officer-annual-report-volume-2 .,Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
Available from: https://www.gov.uk/government/uploads/system/ uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_ strategy.pdf .,OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
Available from: http://www.dh.gov.uk/en/Publicationsand - statistics/Publications/PublicationsPolicyAndGuidance/DH_4007783 .,Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
Available from: http://www.npc.nhs.uk/improving_safety/ improving_quality /.,Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/8e/idr-7-145.PMC4047980.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/80/ijn-9-2727.PMC4047981.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2727–2739International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2727Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJN.S60014Journal name: International Journal of Nanomedicine Journal Designation: Methodology Y ear: 2014 Volume: 9 Running head verso: Bugli et al Running head recto: Synthesis of immunogenic VP6-based nanoconstructs DOI: http://dx.doi.org/10.2147/IJN.S60014 Synthesis and characterization of different  immunogenic viral nanoconstructs from   rotavirus VP6 inner capsid protein Francesca Bugli1 Valeria Caprettini2 Margherita Cacaci1 Cecilia Martini1 Francesco Paroni Sterbini1 Riccardo torelli1 Stefano della longa3 Massimiliano Papi4 Valentina Palmieri4 Bruno giardina5 Brunella Posteraro1 Maurizio Sanguinetti1 Alessandro Arcovito5 1Istituto di Microbiologia,   Università Cattolica del Sacro  Cuore, 2dipartimento di Fisica,   Sapienza Università di Roma, Rome,   3dipartimento di Medicina Clinica,   Sanità Pubblica, Scienze della Vita e  dell’Ambiente, Università dell’Aquila,   l’Aquila, 4Istituto di Fisica, 5Istituto  di Biochimica e Biochimica Clinica,   Università Cattolica del Sacro Cuore,   Rome, ItalyAbstract:  In order to deliver low-cost viral capsomeres from a large amount of soluble viral  VP6 protein from human rotavirus, we developed and optimized a biotechnological platform  in Escherichia coli .",Non-OADS,/arxiv_data1/oa_pdf/f8/80/ijn-9-2727.PMC4047981.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f8/80/ijn-9-2727.PMC4047981.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2739Synthesis of immunogenic VP6-based nanoconstructs Supplementary material Figure S1 hydrodynamic  radius (Rh) number distribution (Pn) of the three VP6 structural assemblies obtained in the three different experimental conditions.,Non-OADS,/arxiv_data1/oa_pdf/f8/80/ijn-9-2727.PMC4047981.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/4b/ijn-9-2779.PMC4047982.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2779–2789International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2779OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5281 8Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Nemmar et al Running head recto: Systemic toxicity of amorphous SiNPs DOI: http://dx.doi.org/10.2147/IJN.S52818 amorphous silica nanoparticles impair vascular  homeostasis and induce systemic inflammation abderrahim Nemmar1 sulayma albarwani2 sumaya Beegam1 Priya Yuvaraju1 Javed Yasin3 samir attoub4 Badreldin h ali5 1Department of Physiology, college  of Medicine and health sciences,   United arab emirates University,   al ain, United arab emirates;  2Department of Physiology, college  of Medicine and health sciences,   sultan Qaboos University, al-Khod,   sultanate of Oman; 3Department  of Internal Medicine, college of  Medicine and health sciences, United  arab emirates University, al ain,   United arab emirates; 4Department  of Pharmacology, college of Medicine  and health sciences, United arab  emirates University, al ain, United  arab emirates; 5Department of  Pharmacology, college of Medicine  and health sciences, sultan Qaboos  University, al-Khod, sultanate   of Oman correspondence: abderrahim Nemmar Department of Physiology, college   of Medicine and health sciences, United  arab emirates University, PO Box 17666,  al ain, United arab emirates T el +971 3 713 7533 Fax +971 3 767 1966 email anemmar@uaeu.ac.a eAbstract:  Amorphous silica nanoparticles (SiNPs) are being used in biomedical,   pharmaceutical, and many other industrial applications entailing human exposure.",Non-OADS,/arxiv_data1/oa_pdf/80/4b/ijn-9-2779.PMC4047982.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/80/4b/ijn-9-2779.PMC4047982.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 2789systemic toxicity of amorphous siNPs  44.,Non-OADS,/arxiv_data1/oa_pdf/80/4b/ijn-9-2779.PMC4047982.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/a5/main.PMC4048000.pdf
http://dx.doi.org/10.1016/j.shaw.2014.01.001Safety and Health at Work 5 (2014) 23 e26,Non-OADS,/arxiv_data1/oa_pdf/a7/a5/main.PMC4048000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/d8/main.PMC4048001.pdf
http://dx.doi.org/10.1016/j.shaw.2013.11.002Safety and Health at Work 5 (2014) 7 e12,Non-OADS,/arxiv_data1/oa_pdf/93/d8/main.PMC4048001.pdf
Available from: http://www.mhlw.go.jp/toukei/itiran/ roudou/saigai/anzen/kenkou07/dl/kenkou07.pdf [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/93/d8/main.PMC4048001.pdf
Available from: http://www.mhlw.go.jp/ english/wp/wp-hw4/dl/health_and_welfare_services_for_the_elderly/ 2011071906.pdf .,Non-OADS,/arxiv_data1/oa_pdf/93/d8/main.PMC4048001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/f4/main.PMC4048002.pdf
http://dx.doi.org/10.1016/j.shaw.2013.11.001Safety and Health at Work 5 (2014) 1 e6,Non-OADS,/arxiv_data1/oa_pdf/46/f4/main.PMC4048002.pdf
Available from: http://www.who.int/patientsafety/safesurgery/ss_checklist/en/ .,Non-OADS,/arxiv_data1/oa_pdf/46/f4/main.PMC4048002.pdf
Available from: http://www.jointcommission.,Non-OADS,/arxiv_data1/oa_pdf/46/f4/main.PMC4048002.pdf
http://epp.eurostat.ec.europa.eu/portal/page/portal/statistics/ search_database [accessed 03.03.14].,Non-OADS,/arxiv_data1/oa_pdf/b2/b8/main.PMC4048003.pdf
"Alexopoulos) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/ 3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/main.PMC4048003.pdf
"http://dx.doi.org/10.1016/j.shaw.2014.01.004 Considerations Concerning the Epidemiology ofOccupational Dermatoses To the Editor Our erudite colleague, in his Letter to the Editor, has made a valiant effort to demonstrate that any piece of medical knowledge can be expanded upon, and made comments on our article [1], some erroneous and some others possibly reminiscent of cases of cognitive ignorance or mispresentation.",Non-OADS,/arxiv_data1/oa_pdf/b2/b8/main.PMC4048003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/56/main.PMC4048004.pdf
http://dx.doi.org/10.1016/j.shaw.2014.01.003Safety and Health at Work 5 (2014) 27 e31,Non-OADS,/arxiv_data1/oa_pdf/64/56/main.PMC4048004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
http://dx.doi.org/10.1016/j.shaw.2014.01.002Safety and Health at Work 5 (2014) 32 e38,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
Available from: http://www.mhlw.go.jp/ toukei/itiran/roudou/saigai/anzen/kenkou07/r1.html .,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
Available from: http://www.research12.jp/h13/pdf/09s.,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
Available from: http://www1.mhlw.go.jp/ topics/kenko21_11/b5.html#A52 .,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
Available from: http://www.mhlw.go.jp/ new-info/kobetu/roudou/gyousei/kantoku/dl/040324-4.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
Available from: http://www.joshrc.org/ wopen/ ﬁles/20011116-004.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a5/6d/main.PMC4048005.pdf
"Alexopoulos) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/ 3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/e6/main.PMC4048006.pdf
"http://dx.doi.org/10.1016/j.shaw.2014.01.004 Considerations Concerning the Epidemiology ofOccupational Dermatoses To the Editor Our erudite colleague, in his Letter to the Editor, has made a valiant effort to demonstrate that any piece of medical knowledge can be expanded upon, and made comments on our article [1], some erroneous and some others possibly reminiscent of cases of cognitive ignorance or mispresentation.",Non-OADS,/arxiv_data1/oa_pdf/e4/e6/main.PMC4048006.pdf
Available from: http://www.arbejdsmiljoforskning.dk/da/publikationer/spoergeskemaer/nosq- 2002/engelsk ; 2002 [accessed 30.10.05] [In English].,Non-OADS,/arxiv_data1/oa_pdf/e4/e6/main.PMC4048006.pdf
"E-mail address: eleni_zorba@yahoo.com (E. Zorba) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/ 3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/e6/main.PMC4048006.pdf
http://dx.doi.org/10.1016/j.shaw.2014.01.005E.C.,OADS,/arxiv_data1/oa_pdf/e4/e6/main.PMC4048006.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/8d/main.PMC4048007.pdf
http://dx.doi.org/10.1016/j.shaw.2013.11.003Safety and Health at Work 5 (2014) 17 e22,Non-OADS,/arxiv_data1/oa_pdf/85/8d/main.PMC4048007.pdf
Available from: http://www.who.int/injection_safety/toolbox/ docs/AM_HCW_Safety.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/8d/main.PMC4048007.pdf
Accessed from: http://www.ccohs.ca/ oshanswers/diseases/needlestick_injuries.html .,Non-OADS,/arxiv_data1/oa_pdf/85/8d/main.PMC4048007.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/5d/main.PMC4048008.pdf
http://dx.doi.org/10.1016/j.shaw.2013.11.004Safety and Health at Work 5 (2014) 13 e16,Non-OADS,/arxiv_data1/oa_pdf/fe/5d/main.PMC4048008.pdf
Available at:http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d125&searchTab=searchByAuthType&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keyword=Enter+keywords&searchType=name&taxonomyPath=&treeNumber=&searchGenericType=biosimilars&genericsKeywordSearch=Submit (accessedOctober 2013).,OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
"Available at: http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d125 (accessedOctober 30, 2013).",Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
"Available at: http://www.celltrion.com/en/BIO/bio02.asp?menu_num=2 (accessed October 30,2013).16.",OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
"Available at: https://www.clinicaltrialsregister.eu/ (accessed October 30, 2013).",Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
Availableat: http://www.mhra.gov.uk/Safetyinformation/Howwemonitorthesafetyofproducts/Medicines/BlackTriangleproducts/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
Available at: http://invivoblog.blogspot.com/2011/10/german-biosimilars-breakthrough-that.html(accessed October 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
Available at: http://gabionline.net/Biosimilars/News/ Greece-says-no-to-automatic-substitution-of-biologicals(accessed October 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
Available at: http://www.linkos.cz/,Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
Available at: http://share.pdfonline.com/ 715d4c29076b42ac83589ca85c3213f1/Gabriel%20Morelli%2012%20febrero%202013.htm (accessedOctober 2013).,Non-OADS,/arxiv_data1/oa_pdf/5c/ce/main.PMC4048039.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50566 | Page 1 of 10Video Article Localization and Relative Quantification of Carbon Nanotubes in Cells with Multispectral Imaging Flow Cytometry Iris Marangon*1, Nicole Boggetto*2, Cécilia Ménard-Moyon3, Nathalie Luciani1, Claire Wilhelm1, Alberto Bianco3, Florence Gazeau1 1Laboratoire Matière et Systèmes Complexes (MSC), CNRS/Université Paris Diderot 2ImagoSeine BioImaging Core Facility, Institut Jacques Monod, CNRS/Université Paris Diderot 3Laboratoire d'Immunopathologie et Chimie Thérapeutique, CNRS/Institut de Biologie Moléculaire et Cellulaire *These authors contributed equally Correspondence to: Florence Gazeau at florence.gazeau@univ-paris-diderot.fr URL: http://www.jove.com/video/50566 DOI: doi:10.3791/50566 Keywords: Bioengineering, Issue 82, bioengineering, imaging flow cytometry, Carbon Nanotubes, bio-nano-interactions, cellular uptake, cell trafficking Date Published: 12/12/2013 Citation: Marangon, I., Boggetto, N., Ménard-Moyon, C., Luciani, N., Wilhelm, C., Bianco, A., Gazeau, F. Localization and Relative Quantification of Carbon Nanotubes in Cells with Multispectral Imaging Flow Cytometry.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/jove-82-50566.PMC4048057.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50566/ Introduction During the last decades, the place of nanoparticles has gained in importance in a wide range of applications.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/jove-82-50566.PMC4048057.pdf
"More recently we showed that during anoxia, NMDARs could  activate Panx1.15 This is in addition to the direct activation of *Correspondence to: Roger J Thompson; Email: rj.thompson@ucalgary.ca Submitted: 01/22/2014; Accepted: 01/23/2014; Published Online: 02/27/2014 http://dx.doi.org/10.4161/chan.27978Pannexin-1 as a potentiator   of ligand-gated receptor signaling Brant e Isakson1,2 and r oger J Thompson3,* 1robert M. Berne Cardiovascular r esearch Center; University of Virginia School of Medicine; Charlottesville, VA USA; 2Department of Molecular Physiology and Biophysics;  University of Virginia School of Medicine; Charlottesville, VA USA; 3Hotchkiss Brain Institute; Department of Cell Biology and Anatomy; University of Calgary; Calgary, AB Canada Keywords:  G-protein coupled receptor, NMDA receptor, adrenergic receptor, alpha1R,   gap junction, hemichannel, ionotropic receptor, pannexin, purinergic Pannexins are a class of plasma membrane spanning pro - teins that presumably form a hexameric, non-selective ion chan - nel.",Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Genomics  2004; 83:706-16;  PMID :15028292 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Cancer Res  2007; 67:1545-54;  PMID:17308093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Trends Neurosci  2010; 33:93-102;  PMID:20022389 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
FEBS Lett 2004; 572:65-8;  PMID:15304325 ;  http://dx.doi.org/10.1016/j.febslet.2004.07.009 6.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Nature  2010; 467:863-7;  PMID:20944749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
EMBO J 2006; 25:5071- 82; PMID:17036048 ; http://dx.doi.org/10.1038/ sj.emboj.76013788.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Nat Med  2012; 18:600-4;  PMID:22426419 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Immunity  2007; 26:433-43;  PMID:17433728 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Biol Chem 2009;  284:18143-51;  PMID:19416975 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Science  2006; 312:924-7;  PMID:16690868 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Neurosci Res 2008; 86:2281- 91; PMID:18381763 ; http://dx.doi.org/10.1002/ jnr.21675 14.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Neurosci 2012;  32:12579-88;  PMID:22956847 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Circ Res 2011; 109:80-5;   PMID:21546608 ; http://dx.doi.org/10.1161/ CIRCRESAHA.110.237594 17.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Pharmacol Rev  2010; 62:405-96;  PMID:20716669 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Prog Brain Res 2008; 169:145-58;   PMID:18394472 ; http://dx.doi.org/10.1016/ S0079-6123(07)00008-8 20.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Nat Rev  Neurosci 2010; 11:459-73;  PMID:20559335 ;  http://dx.doi.org/10.1038/nrn2867 21.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Mol Brain  2013; 6:5;  PMID:23339575 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Nat Rev Neurosci  2010; 11:682-96;  PMID:20842175 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Science 2008; 322:1555-9;  PMID:19056988 ;  http://dx.doi.org/10.1126/science.116520924.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Neuropharmacology 2009;  56:414-21;  PMID:18930747 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Proc Natl Acad Sci U S A 2013;  110:17540-5;  PMID:24101472 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
"Cell 2004; 116(Suppl):S41-3, 2,  S48;  PMID:15055580 ; http://dx.doi.org/10.1016/ S0092-8674(04)00041-8 28.",OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Purinergic Signal 2009; 5:129-37;  PMID:19212823 ;  http://dx.doi.org/10.1007/s11302-009-9141-7 31.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Am J Physiol  Cell Physiol 2008; 295:C752-60;  PMID:18596211 ;  http://dx.doi.org/10.1152/ajpcell.00228.2008 32.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Cardiovasc Pharmacol Ther  2010 ; 15:190-5;  PMID:20200324 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Brain Pathol  2012; 22:295-306;  PMID:21933296 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Front  Cell Neurosci 2014; 7:287;  PMID:24409119 ;  http://dx.doi.org/10.3389/fncel.2013.0028737.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Brain Res 2011; 1394:71- 8; PMID :21536256 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Mol  Neurosci 2012; 46:585-94;  PMID:21932038 ;  http://dx.doi.org/10.1007/s12031-011-9646-8 39.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Nat Med 2012; 18:595- 9; PMID:22447075 ; http://dx.doi.org/10.1038/ nm.2710 40.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Am J Physiol Cell Physiol 2010; 299:C1118- 26; PMID:20668211 ; http://dx.doi.org/10.1152/ ajpcell.00122.2010 41.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Vasc Res  2012; 49:405-16;  PMID:22739252 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Mol Cell Cardiol 2012;  53:165-75;  PMID:22564263 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Biol Chem 2009;  284:20638-48;  PMID:19439413 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Biol Chem 2011; 286:26277-86;   PMID:21606493 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Am J Physiol Cell Physiol 2012; 302:C915- 23; PMID:22159088 ; http://dx.doi.org/10.1152/ ajpcell.00283.2010 46.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Biol  Chem 2013; 288:27571-83;  PMID:23918924 ;  http://dx.doi.org/10.1074/jbc.M113.460865,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Cell Commun Signal  2013; 11:70;  PMID:24047499 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
Biochem Pharmacol 2014; 87:371- 9; PMID:24269631 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
FEBS Lett 2006; 580:239- 44; PMID:16364313 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
J Physiol 2012;  590:4335-50;  PMID:22733659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/ac/chan-8-118.PMC4048300.pdf
"*Correspondence to: Roger J Thompson; Email: rj.thompson@ucalgary.ca Submitted: 10/31/2013; Revised: 12/20/2013; Accepted: 12/23/2013; Published Online: 01/13/2014 http://dx.doi.org/10.4161/chan.27653A critical role for pannexin-1 in activation of innate  immune cells of the choroid plexus Valentyna Maslieieva and r oger J Thompson* Hotchkiss Brain Institute; Department of Cell Biology and a natomy; University of Calgary; Calgary, a B Canada Keywords : pannexin-1, ATP, choroid plexus, epiplexus, macrophage, P2X4, P2X7, calcium, epithelial, chemotaxis Abbreviations:  5-BDBD, 5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one; aCSF, artificial cerebrospinal  fluid; ATP, adenosine-5 ′-triphosphate; BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis  (acetoxymethyl ester); BBG, brilliant blue G; BCSFB, blood-cerebrospinal fluid barrier; BzATP, 3 ′-Benzoylbenzoyl adenosine  5′-triphosphate; CP, choroid plexus; DMSO, dimethyl sulfoxide; IB4, Alexa Fluor 488 isolectin B4 conjugate from Griffonia  simplicifolia; Iba1, ionized calcium binding adaptor molecule 1; Panx1, pannexin-1 epiplexus cells are a population of innate immune cells in the choroid plexus of the brain ventricles.",Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Supplemental Material Supplemental material may be found here: http://www.landes - bioscience.com/journals/channels/article/2765 3,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Methods Mol Biol 2011;  686:101-31;  PMID:21082368 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Microsc Res Tech 1998; 41:43- 56; PMID:9550136 ; http://dx.doi.org/10.1002/ (SICI)1097-0029(19980401)41:1<43::AID- JEMT5>3.0.CO;2-V 4.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
J Neuroimmunol  2008; 199:133-41;  PMID:18539342 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Arch Histol Jpn 1973; 35:133- 40; PMID:4735623 ; http://dx.doi.org/10.1679/ aohc1950.35.133 6.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
J Leukoc Biol  2004; 75:388-97;  PMID:14612429 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Histochemistry 1975; 44:103- 4; PMID:1181335 ; http://dx.doi.org/10.1007/ BF00490425 9.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Cell Tissue Res  2003; 313:259-69;  PMID:12920643 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Glia  2012 ; 60 :1506-17;  PMID:22740309 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Brain Pathol 2008; 18:71-85;  PMID:17924979 ;  http://dx.doi.org/10.1111/j.1750-3639.2007.00104.x 13.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Neuroscience 1994; 63:1169-78;  PMID :7700515 ;  http://dx.doi.org/10.1016/0306-4522(94)90581-9 14.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Brain Res  1995; 699:275-85;  PMID:8616631 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Acta Neuropathol 1992; 84:78- 84; PMID:1502884 ; http://dx.doi.org/10.1007/ BF00427218 17.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Acta Anat (Basel)  1988; 131:241-8;  PMID:3376729 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Annu Rev Immunol 2002; 20:197- 216; PMID:11861602 ; http://dx.doi.org/10.1146/ annurev.immunol.20.083001.084359 19.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Trends Immunol 2007; 28:429- 36; PMID:17845865 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Purinergic Signal 2007; 3:435-45;   PMID:18404456 ; http://dx.doi.org/10.1007/ s11302-007-9082-y 22.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Sci Signal  2010; 3:ra55;  PMID:20664064 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Br J Pharmacol 2007; 152:1283-90;  PMID:17934511 ;  http://dx.doi.org/10.1038/sj.bjp.0707504 25.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Nature 2009; 461:282- 6; PMID:19741708 ; http://dx.doi.org/10.1038/ nature08296 26.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Nat Rev Immunol  2011; 11:201-12;  PMID:21331080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Sci  Signal 2008; 1:ra6;  PMID:18827222 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
EMBO J 2006; 25:5071- 82; PMID:17036048 ; http://dx.doi.org/10.1038/ sj.emboj.7601378 31.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Biochim  Biophys Acta 2013; 1828:79-93;  PMID:22266266 ;  http://dx.doi.org/10.1016/j.bbamem.2012.01.002 32.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Dev Neurobiol 2013; 73:621- 31; PMID:23650255 ; http://dx.doi.org/10.1002/ dneu.22088 34.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Anat Rec 1992; 232:520- 6; PMID:1372795 ; http://dx.doi.org/10.1002/ ar.1092320409 35.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
J Histochem Cytochem  1990; 38:1683-6;  PMID:2212623 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Biochem Biophys  Res Commun 1996; 224:855-62;  PMID:8713135 ;  http://dx.doi.org/10.1006/bbrc.1996.1112 39.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
J Immunol Methods 1998; 216:139- 53; PMID:9760220 ; http://dx.doi.org/10.1016/ S0022-1759(98)00075-1 40.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
BMC Neurosci  2012; 13:53;  PMID:22640172 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Nature 2010; 467:863- 7; PMID:20944749 ; http://dx.doi.org/10.1038/ nature09413,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Neural  Dev 2012; 7:11;  PMID:22458943 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Mol Biol Cell 2009; 20:4313-23;   PMID:19692571 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
J Neurosci 2012;  32:12579-88;  PMID:22956847 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Science  2006; 312:924-7;  PMID:16690868 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Science  2008; 322:1555-9;  PMID:19056988 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Int J Biochem Cell Biol 2010; 42:1753- 6; PMID:20599520 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Nat Neurosci 2005; 8:752-8;   PMID :15895084 ; http://dx.doi.org/10.1038/nn1472 50.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Neuroreport 2005;  16:903-7;  PMID:15931059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Am J Physiol Cell Physiol 2009; 296:C250- 5; PMID:18945939 ; http://dx.doi.org/10.1152/ ajpcell.00433.2008 52.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Tissue Antigens 2011; 78:321-32;  PMID:21988719 ;  http://dx.doi.org/10.1111/j.1399-0039.2011.01780.x 53.,Non-OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
Trends Pharmacol Sci 2007; 28:465- 72; PMID:17692395 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
FEBS Lett 2006; 580:239- 44; PMID:16364313 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/72/chan-8-131.PMC4048302.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Epigenetic changes in newborns of obese parents A Soubry et al 657 &2015 Macmillan Publishers Limited International Journal of Obesity (2015) 650 – 657",Non-OADS,/arxiv_data1/oa_pdf/96/56/ijo2013193a.PMC4048324.pdf
"*Correspondence to: Michele H Jacob; Email: michele.jacob@tufts.edu Submitted: 08/14/2013; Revised: 11/26/2013; Accepted: 12/09/2013; Published Online: 01/06/2014 http://dx.doi.org/10.4161/chan.27470Alternative splice isoforms of small conductance  calcium-activated SK2 channels differ in molecular  interactions and surface levels elizabeth Storer Scholl1,†, antonella Pirone1, Daniel H Cox1, r Keith Duncan2, and Michele H Jacob1,* 1Department of Neuroscience; Tufts University Sackler School of Graduate Biomedical Sciences; Boston, M a US a; 2Department of Otolaryngology;   University of Michigan; a nn a rbor, MI US a †Current affiliation: Department of Molecular Physiology and Biophysics; University of Iowa Carver College of Medicine; Iowa City, I a US a Keywords:  SK channel, nAChR, sensory hair cell, neuron, calcium, calmodulin, olivocochlear, synapse Abbreviations: nAChR: nicotinic acetylcholine receptor; IHCs, inner hair cells; OHC, outer hair cells; CaM, calmodulin;  CaMBD, CaM-binding domain; HC, hippocampus; Ctx, cortex; CICR, Ca2+-induced Ca2+ release Small conductance Ca2+-sensitive potassium (SK2) channels are voltage-independent, Ca2+-activated ion channels  that conduct potassium cations and thereby modulate the intrinsic excitability and synaptic transmission of neurons and  sensory hair cells.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Source: http://multalin.toulouse.inra.fr/multalin/.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Materials and Methods Antibodies Primary antibodies used were: monoclonal anti- α-actinin  (Sigma, http://www.sigmaaldrich.com/catalog/product/sigma/ a5044?lang=en&region=US); monoclonal anti- α-actinin-1  (United States Biological, http://www.usbio.net/item/A0761- 01C?highlight); polyclonal anti-MAGI-2/S-SCAM (Sigma,  http://www.sigmaaldrich.com/catalog/product/sigma/ m2441?lang=en&region=US); polyclonal anti-SK2 potassium  channel (Sigma, http://www.sigmaaldrich.com/catalog/ product/sigma/p0483?lang=en&region=US); monoclonal  anti-SV2 (Developmental Studies Hybridoma Bank, http:// dshb.biology.uiowa.edu/synaptic-vesicles); polyclonal anti-MBP  (maltose binding protein; New England Biolabs, https://www.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"neb.com/products/e8030-anti-mbp-antiserum); monoclonal  anti-GST (glutathione S-transferase, Santa Cruz Biotechnology,  http://www.scbt.com/datasheet-138-gst-b-14-antibody.html);  monoclonal anti-calmodulin (Sigma, http://www.sigmaaldrich.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"com/catalog/product/sigma/c3545?lang=en&region=US);  monoclonal anti-HA (Roche Diagnostics, http://www.roche- applied-science.com/shop/products/anti-ha-biotin-high- affinity-3f10-); monoclonal anti-cortactin (Millipore, http:// www.millipore.com/catalogue/item/05-180); monoclonal  anti-sodium/potassium ATPase (Thermo Scientific, http:// www.pierce-antibodies.com/Sodium-Potassium-ATPase-alpha- 3-antibody-clone-XVIF9-G10-Monoclonal–MA3915.html).",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Secondary antibodies used were: Cy3 donkey anti-mouse IgM  (Jackson ImmunoResearch, http://www.jacksonimmuno.com/ Catalog/catpages/whol-mse.asp); Alexa-Fluor-488 and -594  donkey anti-rabbit and goat anti-mouse IgG (Molecular Probes,  http://products.invitrogen.com/ivgn/en/US/adirect/invitrogen ?cmd=catDisplayStyle&catKey=97901&filterDispName=Alex a+Fluor%26reg%3B&filterType=1&OP=filter&filter=ft_1601 %2Ff_2101 *&_bcs_=H4sIAAAAAAAAAMWP20rEMBCGn yY3FkvagNteVsuKCCIueh%2FT2XagSUoybenbO62HFV28F YYZ5vz9%0Al5mQxWPwzWgoJiK%2FSg4QJjQQ%2F6h3R INQlcj3bPM8p%2BgmpOBbcKnxlosRCTiMkR04dp23kHZk e14X%0AuVpNFhRGWHO5kxwymfFguZMyu%2BC0coSvv kHY3mvLH68ZwnjX6LAkNRAYQu%2BSJ9D8mH6BDR% 2F0P%2BlU%0AVUhu49S6T7rnAzvdYOCTa%2BtrQai9sY1 Q9d3L7YPRVGMcer3caILWh4XBuHgPC09s4N%2FVHXU fz8vb%0AYvku86ToJPjflZTnlbwB4%2F0dHi0CAAA%3D);  horseradish peroxidase (HRP)-conjugated goat anti-mouse and  anti-rabbit (Bio-Rad http://www.bio-rad.com/en-us/product/ hrp-conjugates); HRP-conjugated goat anti-rat (Invitrogen, http://tools.invitrogen.com/content/sfs/manuals/819520_ Rev1008.pdf).",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Ten-micrometer thick cryosections were blocked with  5% normal donkey serum (Jackson Immunoresearch, http:// www.jacksonimmuno.com/Catalog/CatPages/normal.asp) or  0.25% teleost gelatin (Sigma, http://www.sigmaaldrich.com/ catalog/product/sigma/g7765?lang=en&region=US in PBS.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Sections were incubated with primary antibodies for 1 h at RT,  rinsed 3 times with blocking buffer, incubated with secondary  antibodies for 45 min, rinsed, and mounted with coverslips using  Vectashield (Vector Labs, http://www.vectorlabs.com/catalog.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"RT-PCR and α-actinin sequencing Total RNA was isolated from E19 chicken cochlear ducts  using TRIzol Reagent (Invitrogen, http://products.invi - trogen.com/ivgn/product/15596026).",OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"PCR products were subcloned  into pcDNA3.1 (Invitrogen, http://tools.invitrogen.com/ content/sfs/vectors/pcdna3.1-.pdf) and grown on LB-ampicillin  plates.",OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"SK2 clones were amplified by PCR from individual  colonies, and PCR products were digested with the restriction  enzyme Hpy188I (New England Biolabs, https://www.neb.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Q-PCR of Mouse Forebrain SK2 splice variants Total RNA was extracted (Qiagen, http://www.qiagen.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Oocytes  (provided by Joel Richter, University of Massachusetts Medical  School) were obtained from adult Xenopus laevis  frogs and  defolliculated in OR2 (in mM: 82.5 NaCl, 2 KCl, 0.5 MgCl2,  5 HEPES pH 7.6) containing 2mg/ml collagenase (Sigma) and  1mg/ml dispase II (Roche Applied Science, http://www.roche- applied-science.com/shop/products/dispase14301-ii-neutral- protease-grade-ii-).",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Ca2+ solutions were  prepared by adding to our standard internal solution, which  contained 1 mM EGTA, the correct amount of CaCl2 (100 mM  Orion Standard), as calculated with MaxChelator Software  (http://maxchelator.stanford.edu/) to achieve the desired free  [Ca2].",OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Glutathione S-transferase (GST) fusion of full- length human α-actinin-1 was created by cloning into the pGex4T3  vector (GE Healthcare, https://www.gelifesciences.com/gehcls_ images/GELS/Related%20Content/Files/1314716762536/ litdoc28-9545-52PS_AA_06-2009_WEB_20110830172010.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Fusion peptides were expressed in Rosetta-gami 2(DE3)  cells (EMD Chemicals, http://www.emdmillipore.com/life- science-research/rosetta-gami-2de3-competent-cells-*/EMD_ BIO-71351/p_wJab.s1O2lsAAAEjRxl9.zLX) and grown in LB  media containing 0.5M NaCl and 2.5 mM betaine to an optical  density (OD) of 500–700.",OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"For binding assays, equal quantities of SK2- or SK2-ARK- MBP peptides were bound to amylose resin and incubated  with α-actinin-1-GST in Tris-Tx buffer (in mM: 10 Tris pH  7.6, 50 NaCl, 5 EDTA, 30 Na4P2O7, 50 NaF, 0.4 Na3VO4, 1%  Triton X-100) supplemented with protease inhibitor cocktail  (Thermo Scientific, http://www.piercenet.com/browse.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"cfm?fldID=02040806) and phosphatase inhibitor cocktail  (Roche Applied Science, http://www.roche.com/products/ product-details.htm?type=product&id=111).",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Three days after injection, oocytes were incubated  for 30 min at 4 °C in 1mg/ml EZ-Link Sulfo-NHS-LC- Biotin (Thermo Scientific, http://www.piercenet.com/browse.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Streptavidin-agarose beads (Thermo Scientific,  http://www.piercenet.com/browse.cfm?fldID= 01021103) were  added to precipitate biotinylated proteins and washed 4 times in Tris-Tx buffer.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Neuron  2000; 26:595-601;  PMID :10896156 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Neurosci  2004 ;  24:5301 -6; PMID:15190101 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Biol Chem  2003 ; 278:49085 -94;  PMID:13679367 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Science  1996 ; 273:1709 - 14; PMID:8781233 ; http://dx.doi.org/10.1126/ science.273.5282.1709 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Gen Physiol   1998 ; 111:565-81; PMID:9524139 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Neurosci  2011 ; 31:15092 -101;  PMID:22016543 ; http://dx.doi.org/10.1523/ JNEUROSCI.2743-11.20117.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Physiol  2007 ; 583:631- 46; PMID:17627990 ; http://dx.doi.org/10.1113/ jphysiol.2007.136630 8.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Mol Cell Neurosci  2009 ; 40:39- 49; PMID:18848895 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Physiol  2008 ; 586:5471 -85; PMID:18818242 ;  http://dx.doi.org/10.1113/jphysiol.2008.160077 10.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Hear Res  2010 ; 279:1-12 PMID:21187136 ;  http://dx.doi.org/10.1016/j.heares.2010.12.01815.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Hear Res   1997 ; 107:147-59; PMID:9165355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Hear Res   1997 ; 104:191-203; PMID:9119763 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
PLoS  Biol 2009 ; 7:e18; PMID:19166271 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Nature  1998 ; 395:503-7; PMID:9774106 ;  http://dx.doi.org/10.1038/26758 20.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Neuron  2008 ; 59:873- 81; PMID:18817728 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Circ Res   2007 ; 100:112-20; PMID:17110593 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Nat Neurosci  2005 ; 8:642-9;  PMID :15852011 ; http://dx.doi.org/10.1038/nn1449 25.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Proc Natl Acad Sci U S A   2007 ; 104:20594 -9; PMID:18077337 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Neuron  1999 ; 23:93- 103; PMID:10402196 ; http://dx.doi.org/10.1016/ S0896-6273(00)80756-4 27.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Biol Chem  2003 ; 278:25940 -6;  PMID:12734181 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Proc Natl Acad Sci U S A   2009 ; 106:18402 -7; PMID :19815520 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Neuron  2004 ; 43:847- 58; PMID:15363395 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Comp  Physiol A Neuroethol Sens Neural Behav Physiol   2005 ; 191:491-503; PMID :15868189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Mol  Cell Neurosci  2008 ; 38:138-52; PMID:18407517 ;  http://dx.doi.org/10.1016/j.mcn.2008.02.006 32.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Nucleic Acids Res  1989 ; 17:6725 ;  PMID:2780298 ; http://dx.doi.org/10.1093/ nar/17.16.6725 35.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Biochemistry  2007 ; 46:8485 - 97; PMID:17602661 ; http://dx.doi.org/10.1021/ bi0623025 36.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Science  2000 ; 288:2366 - 8; PMID:10875922 ; http://dx.doi.org/10.1126/ science.288.5475.2366 37.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J  Neurophysiol  2004 ; 91:1536 -44; PMID:14657188 ;  http://dx.doi.org/10.1152/jn.00630.2003 39.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Neurosci  2004 ; 24:11160 - 4; PMID :15590932 ; http://dx.doi.org/10.1523/ JNEUROSCI.3674-04.200440.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
Cell Tissue Res   1983 ; 229:467-81; PMID:6839349 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Gen Physiol  2008 ;  132:491-505; PMID:18955592 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Neurosci   2008 ; 28:1865 -70; PMID:18287503 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Biol Chem   2008 ; 283:7455 -63; PMID :18195015 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
J Biol Chem  2006 ; 281:11769 -79;  PMID:16513649 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a3/d3/chan-8-62.PMC4048344.pdf
"Subsequent VCF  studies that removed the native cysteine  residues in hERG found a fast fluorescent  report from the top of S4 that had a left  shifted voltage dependence from the G-V  that was interpreted to track VSD move - ments and a slower fluorescent component  that tracked pore rearrangements resulting Gating charge movement precedes ionic current activation   in hERG channels Samuel J Goodchild and David Fedida* Department of Anesthesiology, Pharmacology and Therapeutics; University of British Columbia; Vancouver, BC Canada Keywords:  hERG, gating currents,  activation, kinetics, potassium channel *Correspondence to: David Fedida; Email:  dfedida@medd.med.ubc.ca Submitted: 09/19/2013 Revised: 10/09/2013 Accepted: 10/10/2013 Posted Online: 10/14/2013 http://dx.doi.org/10.4161/chan.26775 Addendum to: Wang Z, Dou Y, Goodchild SJ,  Es-Salah-Lamoureux Z, Fedida D. Components of  gating charge movement and S4 voltage-sensor  exposure during activation of hERG channels.",OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J  Gen Physiol 2013; 141:431–43; PMID:23478995;   http://dx.doi.org/10.1085/jgp.201210942,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Cell 1995;  81:299-307;  PMID:7736582 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Science  1995; 269:92-5;  PMID:7604285 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J Gen Physiol 2013; 141:431- 43; PMID:23478995 ; http://dx.doi.org/10.1085/ jgp.201210942 4.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Front Pharmacol  2012; 3:83;  PMID:22586397 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Physiol Rev 2012; 92:1393- 478; PMID:22988594 ; http://dx.doi.org/10.1152/ physrev.00036.2011 6.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Proc Natl Acad Sci U S A 2003; 100:10534- 9; PMID:12928493 ; http://dx.doi.org/10.1073/ pnas.1832721100 8.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
PLoS One  2010; 5:e10876;  PMID:20526358 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Methods Enzymol 1998; 293:300- 18; PMID :9711615 ; http://dx.doi.org/10.1016/ S0076-6879(98)93020-8 10.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J  Pharmacol Sci 2008; 108:301-7;  PMID:18987434 ;  http://dx.doi.org/10.1254/jphs.08102FP 11.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Proc Natl Acad Sci U S A 2000;  97:12329-33;  PMID:11005845 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Br J Pharmacol  2007; 151:1368-76;  PMID:17592502 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J Biol Chem 2005; 280:7206- 17; PMID:15528201 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J Physiol 1997; 502:45-60;  PMID:9234196 ;  http://dx.doi.org/10.1111/j.1469-7793.1997.045bl.x 15.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Biophys J  1994; 66:1011-21;  PMID:8038375 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
Nature 1996; 379:833-6;  PMID:8587608 ;  http://dx.doi.org/10.1038/379833a0 18.,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
J Gen Physiol 2012; 140:495- 511; PMID:23071269 ; http://dx.doi.org/10.1085/ jgp.201210823,Non-OADS,/arxiv_data1/oa_pdf/e8/49/chan-8-84.PMC4048346.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50867 | Page 1 of 7Video Article The Cell-based L-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins Kristine M. Cihil1,2, Agnieszka Swiatecka-Urban1,2 1Department of Nephrology, Children's Hospital of Pittsburgh of UPMC 2Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine Correspondence to: Agnieszka Swiatecka-Urban at Agnieszka.Swiatecka-Urban@chp.edu URL: http://www.jove.com/video/50867 DOI: doi:10.3791/50867 Keywords: Basic Protocol, Issue 82, Endocytosis, recycling, plasma membrane, cell surface, EZLink, Sulfo-NHS-SS-Biotin, L-Glutathione, GSH, thiol group, disulfide bond, epithelial cells, cell polarization Date Published: 12/13/2013 Citation: Cihil, K.M., Swiatecka-Urban, A.",Non-OADS,/arxiv_data1/oa_pdf/9a/2d/jove-82-50867.PMC4048355.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50867/ Introduction All living cells process information by trafficking cargo, such as extracellular ligands, microorganisms, nutrients, transmembrane proteins and lipids from the plasma membrane to endocytic vesicles ( i.e.",Non-OADS,/arxiv_data1/oa_pdf/9a/2d/jove-82-50867.PMC4048355.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/9b/ehu009.PMC4048536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"In overweight/obese and normal weight elderly people, the relative share of gut bacteria and ShannonHigher blood glucose level associated with body mass index and gut microbiota Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"Intestinal microbiota in healthy volunteers (HE) versus hospitalized patients (PE) and in normal weight versus overweight elderly people (prevalence, %; count log cfu/g median *25%; 75%)1 Volunteers (HE) and hospitalized (PE)Normal (BMI B25) and overweight (BMI /C2125) BacteriaTotal N/C3038Group HE N/C3019Group PE N/C3019BMIB25 N/C3013BMI/C2125 N/C3025 Total count 100% 100% 100% 100% 100% 10.2 9.9 10.7 10.3 8.3 (9.9; 10.7) (9.8; 10.1)a(10.2; 11.2)a(9.5; 11)c(6; 9.3)c Anaerobes 100% 100% 100% 100% 100%Prevalence 9.8 9.8 10.0 9.8 6.4 Count (9.6; 10.4) (9.6; 9.9) (9.3; 10.9) (9.6; 10.3) d(5.5; 8.6)d Bacteroides 97% 100% 95% 92% 100% Prevalence 9.6 9.6 9.6 9.6 9.5Count (9.3; 10.3) (9.4; 9.8) (9.2; 10.9) (9.6; 9.9) (9.2; 10.4)Bifidobacteria 50% 47% 53% 31% 60%Prevalence 9.3 9.3 9.3 8.8 9.3Count (8.6; 9.6) (8.5; 9.4) (8.6; 9.8) (8.2; 9.3) (8.8; 9.8)Anaerobic cocci 73% 79% 68% 62% 74% Prevalence 8.8 8.9 8.3 8.45 8.9 Count (8.1; 9.3) (8.6; 9.3) (7; 9.1) (7.8; 8.9) (8.1; 9.3)Clostridia 39% 53% 26% 46% 36%Prevalence 0 7.3 0 9.1 9.0Count (0 /C18.8) (0 /C19.25) (0 /C13.6) (7.8; 9.5) (7.3; 9.5) Lactobacilli 100% 100% 100% 100% 100%Prevalence 7.2 6.3 7.8 7.3 6.8Count (5.5; 8.6) (4.5; 7.3) b(6.3; 9.3)b(4.6; 8.4) (5.9; 8.6) Coliforms 94% 100% 89% 100% 96% Prevalence 8.3 7.3 9.3 8.3 8.3Count (6.3; 9.3) (6.3; 8.3) (7.7; 9.8) (6.3; 9.2) (6.2; 9.3)Staphylococci 84% 88% 88% 85% 76%Prevalence 9.2 7.3 9.7 8.3 9.6Count (7.3; 9.8) (5.3; 8.5) (9.2; 10.2) (6.8; 8.9) e(7.2; 10.1)e Streptococci 60% 50% 77% 62% 60%Prevalence 9.4 9.3 10.3 9.4 10.0 Count (8.7; 10.5) (8.5; 9.4) (9.6; 10.8) (9; 9.5) (8.5; 10.89) 1Data were analyzed using Student’s t-test for unpaired samples for continuous variables or Mann /C1Whitney rank sum test (non-parametric distribution) and Chi-square test for categorical variables.ap/C300.004;bp/C300.02;cpB0.001;dpB0.001;ep/C300.037.Higher blood glucose level associated with body mass index and gut microbiota Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"PLos One 2009; 4: e7125.Higher blood glucose level associated with body mass index and gut microbiota Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 22857 - http://dx.doi.org/10.3402/mehd.v25.22857",Non-OADS,/arxiv_data1/oa_pdf/53/14/MEHD-25-22857.PMC4048595.pdf
http://dx.doi.org/10.1002/ smll.201300024 .,Non-OADS,/arxiv_data1/oa_pdf/37/57/main.PMC4048727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/1d/main.PMC4048842.pdf
"Commonly utilised promoters driving the reporter genes or genetic payload include Phosphoglycerate kinase promoter (PGK), Elongation factor 1 alpha promoters (EF-1) and Cytomegalovirus http://dx.doi.org/10.1016/j.fob.2014.02.008 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/6f/1d/main.PMC4048842.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: GFP, Green Fluorescent Protein; LTR, Long Terminal Repeat; PGK, Phosphoglycerate kinase promoter; EF-1, Elongation factor 1 alpha promoter; CMV,Cytomegalovirus promoter; UCOE, ubiquitous chromatin opening element pro-moter; VSV-g, vesicular stomatitis virus; 293T, Human embryonic kidney cells; 7- AAD, 7-Aminoactinomycin D; IVF, in vitro fertilisation; AZT, azidodeoxythimidine ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/6f/1d/main.PMC4048842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/09/main.PMC4048843.pdf
http://dx.doi.org/10.1016/j.fob.2014.03.007 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/09/main.PMC4048843.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: DAPT, N-(N-(3,5-diﬂuorophenacetyl)- L-alanyl)-S-phenylglycine t-butyl ester; DiD, 1,10-dioctadecyl-3,3,30,30-tetramethylindodicarbocyanine per- chlorate; LDL, low density lipoprotein; LDLR, low density lipoprotein receptor ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/84/09/main.PMC4048843.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.007 .",OADS,/arxiv_data1/oa_pdf/84/09/main.PMC4048843.pdf
"J., http://dx.doi.org/ 10.1042/BJ20130930 .",Non-OADS,/arxiv_data1/oa_pdf/84/09/main.PMC4048843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
"As protein sequences are obtained primarily by genome sequencing, the location of post-translational modiﬁcations – such as disulﬁde bonds – is usually unknown for the majority of http://dx.doi.org/10.1016/j.fob.2014.03.003 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Acc, prediction accuracies; FN, false negatives; FP, false positives; PDB, Protein Data Bank; TN, true negatives; TP, true positives ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
Real protein sequence dataset Entries in Protein Data Bank (PDB [22]) were ﬁltered at 25% se- quence identity level using BlastClust ( http://www.ncbi.nlm.nih.- gov/blast/Blast/ ) to remove redundant sequences.,OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
"According to the UniProt annotations [30] (http://www.uni- prot.org/ ) the 3881 polypeptide chains can be split into three groups: 1783 intracellular, 1024 extracellular and 910 transmem- brane proteins.",OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
Cys oxidation prediction The oxidation states of cysteines were predicted according to SecretomeP2.0 [31] (http://www.cbs.dtu.dk/services/SecretomeP/ ) predictions.,OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.003 .",OADS,/arxiv_data1/oa_pdf/94/ef/main.PMC4048844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/02/main.PMC4048845.pdf
This MYC/MAX complex speciﬁcally binds to the consensus motif termed E-box (50-CACGTG-30) and http://dx.doi.org/10.1016/j.fob.2014.03.004 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/b9/02/main.PMC4048845.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviation: PI polyamide, pyrrole–imidazole polyamide ⇑Corresponding author at: Innovative Therapy Research Group, Nihon University Research Institute of Medical Science, Nihon University School of Medicine, 30-1Oyaguchi Kami-Cho, Itabashi, Tokyo 173-8610, Japan.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/main.PMC4048845.pdf
"[18] and Bioconductor ( http://www.bioconductor.org/ )[19].T o identify the differentially expressed genes, the rank products method [20] was applied to DFW quantiﬁed data.",OADS,/arxiv_data1/oa_pdf/b9/02/main.PMC4048845.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.004 .References [1]Tan, M.L., Choong, P.F.",OADS,/arxiv_data1/oa_pdf/b9/02/main.PMC4048845.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/e8/main.PMC4048846.pdf
http://dx.doi.org/10.1016/j.fob.2014.03.002 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/3b/e8/main.PMC4048846.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: APN, adiponectin; KO, adiponectin deﬁcient mice; HF/HS, high fat/high sucrose diet; KO (WT–KO), KO partner of WT–KO; MAF, mature adipocytefraction; NC, normal chow diet; SVF, stromal vascular fraction; WAT mes, mesenteric white adipose tissue; WAT sub, subcutaneous white adipose tissue; WT (WT–KO), WT partner of WT–KO; WT (WT–WT), WT partner of WT–WT; WT, wild type mice; WT–KO, parabiosis between WT and KO; WT–WT, parabiosis between WT and WT ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/3b/e8/main.PMC4048846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/eb/main.PMC4048847.pdf
http://dx.doi.org/10.1016/j.fob.2014.03.005 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/2e/eb/main.PMC4048847.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: AQP, aquaporin; ER, endoplasmic reticulum; GFP, green ﬂuorescent protein; DsRM, DsRed-Monomer ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/2e/eb/main.PMC4048847.pdf
"Acta, http://dx.doi.org/ 10.1016/j.bbagen.2013.10.039 .",OADS,/arxiv_data1/oa_pdf/2e/eb/main.PMC4048847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/29/main.PMC4048849.pdf
Similarly as ob- http://dx.doi.org/10.1016/j.fob.2014.02.012 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/29/main.PMC4048849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/60/29/main.PMC4048849.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.02.012 .",OADS,/arxiv_data1/oa_pdf/60/29/main.PMC4048849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/42/main.PMC4048850.pdf
"found that mTOR (mammalian target of rapamycin) signaling, which controls autophagy, mediates C. jejuni induced colitis in IL-10/C0//C0mice independent of T-cell http://dx.doi.org/10.1016/j.fob.2014.03.008 2211-5463/ /C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/b4/42/main.PMC4048850.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CCV, Campylobacter-containing vacuole; CD, Crohn’s disease; CQD, chloroquine diphosphate; Ct, threshold cycle; IBD, inﬂammatory boweldiseases; MOI, Multiplicity of Infection; TEM, transmission electron microscopy ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/b4/42/main.PMC4048850.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.03.008 .",OADS,/arxiv_data1/oa_pdf/b4/42/main.PMC4048850.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5212 | DOI: 10.1038/srep05212 5",Non-OADS,/arxiv_data1/oa_pdf/0e/37/srep05212.PMC4048882.pdf
"Transgenic animals .Transgenic animals were created using Gateway vectors and the Tol2 transgenesis system 28,40(http://chien.neuro.utah.edu/tol2kitwiki/index.php/ Main_Page).",OADS,/arxiv_data1/oa_pdf/ea/05/srep05222.PMC4048883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/05/srep05222.PMC4048883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5222 | DOI: 10.1038/srep05222 8",Non-OADS,/arxiv_data1/oa_pdf/ea/05/srep05222.PMC4048883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/dd/srep05211.PMC4048884.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5211 | DOI: 10.1038/srep05211 7",Non-OADS,/arxiv_data1/oa_pdf/a1/dd/srep05211.PMC4048884.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/f3/srep05209.PMC4048886.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5209 | DOI: 10.1038/srep05209 9",Non-OADS,/arxiv_data1/oa_pdf/f5/f3/srep05209.PMC4048886.pdf
"The log P value for N,N,N 9,N9-TMPD is for hexane/water.‘Log P values were calculated using ChemDraw (http://www.cambridgesoft.com) Mediator E0(V) Mean i ss/nA 61SE.",OADS,/arxiv_data1/oa_pdf/31/10/srep05216.PMC4048887.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5216 | DOI: 10.1038/srep05216 9",Non-OADS,/arxiv_data1/oa_pdf/31/10/srep05216.PMC4048887.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5217 | DOI: 10.1038/srep05217 7",Non-OADS,/arxiv_data1/oa_pdf/79/8c/srep05217.PMC4048888.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/d8/srep05223.PMC4048889.pdf
"Data were smoothed and baseline corrected in R 2.15.2 (R Core Team 2012; http://www.R-project.org/) using the ‘sgolay’ function in the ‘signal’ package (Liland & Mevik 2012, http://CRAN.R-project.org/package 5baseline), and the ‘baseline’ function in the ‘baseline’ package (Signal developers 2013, http://r-forge.r-project.org/projects/signal/), respectively.",OADS,/arxiv_data1/oa_pdf/3e/a9/srep05226.PMC4048910.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3e/a9/srep05226.PMC4048910.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5226 | DOI: 10.1038/srep05226 6",Non-OADS,/arxiv_data1/oa_pdf/3e/a9/srep05226.PMC4048910.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5224 | DOI: 10.1038/srep05224 6",Non-OADS,/arxiv_data1/oa_pdf/88/95/srep05224.PMC4048911.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5214 | DOI: 10.1038/srep05214 6",Non-OADS,/arxiv_data1/oa_pdf/bf/5f/srep05214.PMC4048912.pdf
Growth parameters were generated with the Length Frequency Distribution Analysis (LFDA) Version 5 software package (http://www.fmsp.org.uk/Software.,OADS,/arxiv_data1/oa_pdf/d6/32/srep05151.PMC4048913.pdf
Tropical cyclone report: Tropical Storm Matthew (ALI52010) 23–26 September 2010 (http://www.nhc.noaa.gov/pdf/TCR-AL152010_Matthew.,OADS,/arxiv_data1/oa_pdf/d6/32/srep05151.PMC4048913.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5151 | DOI: 10.1038/srep05151 7",Non-OADS,/arxiv_data1/oa_pdf/d6/32/srep05151.PMC4048913.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5219 | DOI: 10.1038/srep05219 6",Non-OADS,/arxiv_data1/oa_pdf/bb/44/srep05219.PMC4048915.pdf
"2010Government of HaitiPort-au-Prince http://www.caricom.org/jsp/ communications/earthquake_haiti_january_2010/action_plan_national_recovery_haiti.pdf ; See also, Haiti’s earthquake death toll revised to at least 250,000.",Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
"March 31, 2010; Available at http://www.haiticonference.org/communique.htmlCullen and Ivers Page 11 Health Hum Rights .",Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Jan 22.2010 Available at http://www.nytimes.com/2010/01/23/world/americas/23haiti.html?,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.sphereproject.org/ 5.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.fantaproject.org/downloads/pdfs/ HFIAS_v3_Aug07.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2010 Available at http://groups.google.com/group/ccc-mhaiti/web/displacement- tracking-matrix?_done=%2Fgroup%2Fcccmhaiti%3F Humanitarian bulletin.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://oneresponse.info/Disasters/Haiti/Coordination/publicdocuments/Humanitarian %20Bulletin%20No4.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2010 Available at http://oneresponse.info/Disasters/Haiti/Protection/publicdocuments/ Representative%20Secretary%20General%20-%20Haiti%20Memorandum %20%2017%20March.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
1966; 2200A(XXI) Available at http://www2.ohchr.org/english/law/ccpr.htm .,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://go.worldbank.org/45OHF8VEH0 14.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2010 Available at http://ijdh.org/wordpress/wp- content/uploads/2010/06/UN-HRC-full_report.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://siteresources.worldbank.org/DISABILITY/Resources/News---Events/ 463933-1166477763817/EdisNatDisas.doc 16.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
(see note 9)Available at http://wwwbrookings.edu/~/media/Files/rc/reports/2008/spring_natural_disasters/ spring_natural_disasters.pdfCullen and Ivers Page 12 Health Hum Rights .,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at https://www.cimicweb.org/cmo/haiti/Crisis %20Documents/Protection%20Cluster/Jomt%20Secunty%20Assessment%20report%20- %20Final.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Jun 24.2010 Available at http://www.nytimes.com/2010/06/24/world/americas/24haiti.html?,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
"Available at http://www.amnesty.org/en/ library/asset/AMR36/004/2008/en/f8487127-b1a5-11dd-86b0-2b2f60629879/ amr360042008eng.pdf Gomez AM, Speizer IS, Beauvais H. Sexual violence and reproductive health among youth in Port-au-Prince, Haiti.",Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
"Available at http://ijdh.org/wordpress/wp-content/ uploads/2010/07/Haiti-GBV-Report-Final-Compressed.pdf Kolbe, AR.",Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2010 2010 Available at http://groups.google.com/group/assessmentshaiti 25.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.jubileeusa.org/fileadmin/user_upload/Resources/Policy_Archive/haitire- port06.pdf 26.,OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.irc.nl/page/2472 World Health Organization (WHO).,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.who.int/water_sanitation_health/monitoring/jmp2008.pdf 30. WHO (see note 29).,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://siteresources.worldbank.org/ INTLAC/Resources/PDNA_Haiti-2010_Working_Document_EN.pdf 34.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.iom.ch/jahia/webdav/shared/ shared/main-site/published_docs/brochures_and_info_sheets/IOMFactSheet.pdfCullen and Ivers Page 13 Health Hum Rights .,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2010 Available at http://news.yahoo.com/s/ap/20100911/ap_on_re_la_am_ca/cb_haiti_earthquake_rubble 37.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.usaid.gov/ policy/ads/200/pd19.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
2008 Available at http://news.bbc.co.uk/2/hi/ americas/7331921.stm 41.,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.plosmedicine.org/article/info:doi/ 10.1371/)ournal.pmed.0040260 .,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available at http://www.wfp.org/stories/haiti-three-pronged-operation- gets-food-hungriestCullen and Ivers Page 14 Health Hum Rights .,Non-OADS,/arxiv_data1/oa_pdf/03/8a/nihms-587801.PMC4048938.pdf
Available  from: http://phi.uhce.ox.ac.uk/about.php.,Non-OADS,/arxiv_data1/oa_pdf/bf/1c/IJSS-8-1.PMC4049033.pdf
Geneva:  World Health Organization; 2012 Available from: http://www.who.int/mediacentre/factsheets/fs328/en/.,Non-OADS,/arxiv_data1/oa_pdf/ef/e8/JGID-6-59.PMC4049041.pdf
Available from: http://www.idsp.,Non-OADS,/arxiv_data1/oa_pdf/ef/e8/JGID-6-59.PMC4049041.pdf
"For  information about the NHLBI Grading the Strength of Recommendations, go to http://www.nhlbi.nih.gov.",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"For  information about the NHLBI Grading the Strength of Recommendations, go to http://www.nhlbi.nih.gov.",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed March 20,  2014, at http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm6135a2.htm).",OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed March 20,  2014, at http://www.cms.gov/ Research-Statistics-Data-and-Systems/Statistics-Trends-and- Figure 2:  Suggested Steps to Manage Cholesterol.",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed March 20, 2014, at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6004a5.htm).",OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed March 20, 2014, at http://www.uspreventiveservicestaskforce.org/uspstf08/lipid/lipidrs.",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed March 20, 2014, at http://my.americanheart.org/cvriskcalculator).",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
"(Accessed  March 20, 2014, at  http://www.onlinelibrary.wiley.com/ doi/10.1002/14651858.CD004816.pub4/abstract).",Non-OADS,/arxiv_data1/oa_pdf/9e/3b/NAJMS-6-191.PMC4049051.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ad/c9/NAJMS-6-199.PMC4049052.pdf
"(Accessed  November 23, 2013, at  http://www.cdc.gov/heartdisease/ facts.htm).",Non-OADS,/arxiv_data1/oa_pdf/92/22/NAJMS-6-215.PMC4049054.pdf
"(Accessed  November 23, 2013, at https://www.djaverages.com/?go=industrial-index- 2 data&report=performance).",OADS,/arxiv_data1/oa_pdf/92/22/NAJMS-6-215.PMC4049054.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/da/64/NAJMS-6-219.PMC4049055.pdf
http://dx.doi.org/10.1016/j.gpb.2013.10.002,OADS,/arxiv_data1/oa_pdf/0a/02/main.PMC4049090.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.gpb.2013.",OADS,/arxiv_data1/oa_pdf/0a/02/main.PMC4049090.pdf
Available from: < http://commonfund.nih.gov/pdf/ Metabolomics_Workshop.pdf >.,OADS,/arxiv_data1/oa_pdf/0a/02/main.PMC4049090.pdf
"To determine the evolutionary relationships of the recent vir- ulent A. hydrophila (VAh) isolates, a gyrB -based phylogenetic analysis was conducted using a total of 264 Aeromonas strains downloaded from the Aeromonas multilocus sequence typing (MLST) database ( http://www.pubmlst.org/aeromonas ) (18) and including other strains of U.S. and non-U.S. origin (see Ta-ble S1 in the supplemental material).",OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
"In addi- tion to this multilocus sequence-based phylogeny, we searched theAeromonas PubMLST database ( http://www.pubmlst.org/ aeromonas ) (18) using gyrB ,groL ,gltA,metG ,ppsA , and recA gene-speciﬁc sequences of isolates ML09-119, S04-690, and ZC1,and we found that these three isolates belong to sequence type(ST) ST251, which until this study contained only Aeromonas hy- drophila isolate XS91-4-1.",OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.1128/CMR.00039-09 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1016/0959-8030(94)90033-7 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1111/j.1365 -2109.2011.02905.x .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.3354/dao046023 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.3354/dao02332 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
2013(3):458 – 466. http://dx.doi.org/10.7541/2013.44 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1126/ science.1064875 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.1080/08997659.2012.711267 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
41(6):51. http://dx.doi.org/10.1051/vetres/2010022 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.1577/1548-8659(1978)107 /H11021105:ZOTGCI /H110222.0.CO;2 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1128/AEM.00708-11 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1007/ s11515-007-0024-4 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.3923/pjbs.2004.258.268 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
BMC Genomics 9:566. http://dx.doi.org/10.1186/1471-2164-9-566 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1371/journal.pone.0012253 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.1016/0168-1605(96)00972-5 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/ 10.1016/j.syapm.2010.11.014 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1016/ j.syapm.2012.12.007 .,OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1093/bioinformatics/btl529 .,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1093/molbev/msr121 .Asian Origin of U.S.,Non-OADS,/arxiv_data1/oa_pdf/54/8c/mBio.00848-14.PMC4049099.pdf
http://dx.doi.org/10.1097/QAD.0b013e328322ffac .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1016/S0065-2164(08)01005 -8.,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1016/ 0140-6736(90)92283-N .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
77:4345– 4355. http://dx.doi.org/10.1128/IAI.00542-09 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
Biophys.Acta 1788: 842– 857. http://dx.doi.org/10.1016/j.bbamem.2008.10.022 .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
6:625– 634. http://dx.doi.org/10.1038/ nrmicro1952 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
72:4985– 4995. http://dx.doi.org/ 10.1128/IAI.72.9.4985-4995.2004 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1099/ jmm.0.05230-0 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1371/ journal.pone.0035455 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1016/S0002-9440(10)63734-0 .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1172/JCI41963 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
166: 421– 432. http://dx.doi.org/10.1016/S0002-9440(10)62265-1 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1086/341564 .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.4161/viru.18685 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1177/ 0300060513504365 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1099/ mic.0.051524-0 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1128/ IAI.72.4.2229-2239.2004 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1128/IAI.01065-08 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1074/ jbc.M112.353375 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
69:4536 – 4544. http://dx.doi.org/10.1128/IAI.69.7.4536-4544.2001 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1371/journal.pone.0045083 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1111/j.1462-5822.2012.01819.x .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1371/journal.pone.0048570 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07632.x .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1128/IAI.00768-06 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1371/journal.pone.0047853 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2001.02236.x .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1128/EC.00120-07 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1111/j.1462 -5822.2008.01128.x .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
19:19. http://dx.doi.org/10.1186/1423-0127-19-19 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1074/jbc.M112.389676 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1107/S0907444913017642 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1016/j.mycres.2007.11.013 .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1096/fj.04-3458fje .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1128/AAC.35.4.726 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/ 10.1016/0003-2697(84)90553-0 .,OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1074/jbc.M111.279646 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1128/IAI.70.10.5676 -5683.2002 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1139/w06-004 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1086/317937 .,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
http://dx.doi.org/10.1128/IAI.00554-13 .Fungal Metalloprotease Promotes Invasion of CNS May/June 2014 Volume 5 Issue 3 e01101-14®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/2b/ba/mBio.01101-14.PMC4049100.pdf
Microarray data are available at the NCBI Gene Expression Omnibus website ( http://www.ncbi.nlm.nih .gov/geo/ ) under accession number GSE57948.Lsr2 Is a Global Transcriptional Regulator May/June 2014 Volume 5 Issue 3 e01106-14®mbio.asm.org 9,OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1111/j.1462 -5822.2005.00612.x .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
188: 633– 641. http://dx.doi.org/10.1128/ JB.188.2.633-641.2006 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1128/JB.00733-08 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1073/ pnas.0913551107 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1371/ journal.ppat.0030087 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1038/nrmicro1598 .,OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
2:391– 400. http://dx.doi.org/10.1038/nrmicro883 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
48: 77– 84. http://dx.doi.org/10.1046/j.1365-2958.2003.03425.x .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1128/JB.00926 -09.,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
2:105. http://dx.doi.org/10.3389/fmicb.2011.00105 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1016/S0962 -8479(97)90004-6 .,OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
57:395– 418. http://dx.doi.org/10.1146/annurev.micro.57.030502.090938 .15.,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1038/31159 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1128/ IAI.70.7.3371-3381.2002 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1099/mic.0.024802-0 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/ 10.1038/nature12337 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/ 10.1146/annurev.micro.55.1.139 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/ 10.1002/path.2055 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1084/jem.20030205 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
48:833– 843. http://dx.doi.org/10.1046/j.1365 -2958.2003.03474.x .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
Nature 351:456 – 460. http://dx.doi.org/10.1038/351456a0 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/ 10.1128/JB.187.22.7596-7606.2005 .,OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
Microbiology 153: 4166 – 4173. http://dx.doi.org/10.1099/mic.0.2007/012419-0 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1385/1-59259-147 -7:335 .,Non-OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
http://dx.doi.org/10.1016/j.tube.2009.06.001 .,OADS,/arxiv_data1/oa_pdf/50/8a/mBio.01106-14.PMC4049101.pdf
"The INSeq data analysis was performed using the online software ESSENTIALS ( http://bamics2.cmbi.ru.nl/ websoftware/essentials ) (16, 52) and the A. baumannii ATCC 17978 ge- nome sequence (GenBank accession number CP000521).",OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
Raw sequencing readsare available at http://dhcp-165-124-221-156.mimnet.northwestern.edu/ ~hauserlab/inseq/index.html .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1111/j.1574 -6976.2012.00344.x .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
3:148. http://dx.doi.org/10.3389/ fmicb.2012.00148 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/journal.ppat.1003068 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/IAI.06279-11 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/IAI.00016-10 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/IAI.00704-12 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1086/ 596317 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1093/infdis/jiu024 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
Microbiol.11:435– 442. http://dx.doi.org/10.1038/nrmicro3033 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1073/ pnas.0906627106 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002828 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003582 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1016/j.chom.2009.08.003 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
"http://dx.doi.org/10.1128/IAI.00889-09 .16.Zomer A, Burghout P, Bootsma HJ, Hermans PW, van Hijum SA.",OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/ journal.pone.0043012 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
4:174. http://dx.doi.org/10.1038/msb.2008.10 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
171: 417– 436. http://dx.doi.org/10.1007/s12010 -013-0372-2 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
BMCBioinformatics 4:41. http://dx.doi.org/10.1186/1471-2105-4-41 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1099/mic.0.2008/ 019471-0 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
78:3993– 4000. http://dx.doi.org/10.1128/ IAI.00366-10 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
89:816 – 830. http://dx.doi.org/10.1111/mmi.12300 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/IAI.00008-10 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1046/j.1365-2958.2003.03638.x .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
8:216. http://dx.doi.org/ 10.1186/1471-2180-8-216 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/ journal.ppat.0040037 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/IAI.00925 -10.,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1016/0966-842X(94)90006 -X.,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/ 10.1128/IAI.01029-08 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2004.04353.x .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/ 10.1128/JB.184.1.224-232.2002 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/JB.00505 -13.,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1016/ j.resmic.2010.10.010 .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/AAC.01388-10 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/ JB.183.11.3310-3317.2001 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
182: 6451– 6455. http://dx.doi.org/10.1128/JB.182.22.6451 -6455.2000 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1371/ journal.pone.0017027 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/ IAI.01240-06 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
11:31– 41. http://dx.doi.org/10.1111/j.1365-2958.1994.tb00287.x .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
54:808 – 822. http://dx.doi.org/10.1111/j.1365 -2958.2004.04316.x .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
190:4736 – 4748. http://dx.doi.org/10.1128/JB.00089-08 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1128/AEM.02147-06 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
71:4595– 4607. http://dx.doi.org/ 10.1128/IAI.71.8.4595-4607.2003 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1038/ nprot.2011.417 .,Non-OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1016/0378-1119(95)00055-B .,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
http://dx.doi.org/10.1038/nprot.2006.24 .Wang et al.,OADS,/arxiv_data1/oa_pdf/c9/90/mBio.01163-14.PMC4049102.pdf
"Publicly available metag- enomes from Alaskan permafrost (25), soil biomes (26), and soils exposedto a decade of warming (40) were downloaded from the DOE Joint Ge-nome Institute ( http://www.jgi.doe.gov ), MG-RAST ( http:// metagenomics.anl.gov ), and NCBI Sequence Read Archive Web servers, respectively.",OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1126/ science.1186120 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1038/ nature10322 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1126/science.1176985 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1098/ rstb.2011.0377 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
2:410 – 416. http://dx.doi.org/10.1038/nclimate1458 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1016/S0065-2911(06)52003-X .,OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
66: 1540. http://dx.doi.org/10.2136/sssaj2002.1540 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/ 10.1128/AEM.69.6.3517-3525.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1073/ pnas.1211238109 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
7:417– 426. http://dx.doi.org/ 10.1038/ismej.2012.125 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1016/j.febslet.2004.05.060 .,OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1111/j.1574 -6968.2008.01362.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1111/j.1574 -6941.2011.01071.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1111/1462-2920.12478 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
162: 61– 68. http://dx.doi.org/ 10.1111/j.1574-6968.1998.tb12979.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/ AEM.00231-06 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/AEM.02484-09 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/AEM.02993-09 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1101/ gr.5969107 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/MMBR.00009-08 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1038/nature10576 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/ 10.1073/pnas.1215210110 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/ AEM.69.12.7467-7479.2003 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1093/molbev/msn146 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/AEM.00254-09 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/mBio.00592-13 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
BMCBioinformatics 12:198. http://dx.doi.org/10.1186/1471-2105-12-198 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1093/ nar/gkq747 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1142/9789814366496_0026 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1128/ AEM.03443-13 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1038/ismej.2011.147 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
BMC Bioin- formatics 10:421. http://dx.doi.org/10.1186/1471-2105-10-421 .,OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
http://dx.doi.org/10.1371/journal.pcbi.1002195 .,Non-OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
BMC Bioinformatics 12:77.http://dx.doi.org/ 10.1186/1471-2105-12-77 .,OADS,/arxiv_data1/oa_pdf/2c/58/mBio.01193-14.PMC4049103.pdf
Transposon mutagenesis has been conducted at a large scale appropriate for saturation for various M. tuberculosis strains (17).TnHimar1 insertion mutants are available for many genes from the Target website ( http://webhost.nts.jhu.edu/target/ ) and are valuable tools for mycobacterial genetics.,OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/ 10.1016/S0923-2508(00)00119-4 .,OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1038/ nature00935 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1038/nm765 .,OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1007/s00018-004-4513-1 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1054/tuld.1998.0007 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1007/978-1-59745-207-6_19 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
5:23.http://dx.doi.org/ 10.1186/1475-2859-5-S1-S23 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1038/ nmeth996 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07099.x .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
77:642– 657. http://dx.doi.org/10.1111/j.1365 -2958.2010.07235.x .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1128/JCM.06192-11 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
http://dx.doi.org/10.1128/ IAI.72.5.3031-3037.2004 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
Science 260: 819 – 822. http://dx.doi.org/10.1126/ science.8484123 .,Non-OADS,/arxiv_data1/oa_pdf/a2/95/mBio.01245-14.PMC4049104.pdf
"It is importantto note, however, that individuals who had previously acquiredimmunity were not included in the calculation of case fatalityrates, because multiple clinical infections of YF in one individualhave not been documented in the historical literature (15, 18)and are considered exceedingly rare ( http://www.cdc.gov/travel -training/local/HistoryEpidemiologyandVaccination/page24492.html ).",Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
Data analysis was performed in R Studio using the contingency tables for the raw data ( http://www.rstudio.com/ ).,OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
"http://dx.doi.org/ 10.1038/382722a0 .3.County, Shelby TN Census.",OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1016/j.cll.2010.01.001 .,OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1371/ journal.pone.0011671 .,Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/ 10.1371/journal.pone.0059067 .,Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://www.who.int/csr/disease/yellowfev/ YellowFeverBurdenEstimation_Summary2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1146/ annurev.ento.52.110405.091454 .,Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
1:419 – 436. http://dx.doi.org/10.2307/1170791 .,Non-OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1353/ jsh.2001.0058 .,OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
34:855– 865. http://dx.doi.org/10.1016/ 0277-9536(92)90255-O .,OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1093/clinids/ 9.1.165 .,OADS,/arxiv_data1/oa_pdf/e0/f0/mBio.01253-14.PMC4049105.pdf
http://dx.doi.org/10.1038/nrmicro1688 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://www.who.int/tb/publications/global_report/en/ .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1038/nm0396-334 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1038/nm765 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1128/ IAI.72.5.3031-3037.2004 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
71:4190 – 4192. http://dx.doi.org/10.1128/IAI.71.7.4190 -4192.2003 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1128/IAI.73.2.1196-1203.2005 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
Vaccine 29: 4839 – 4847. http://dx.doi.org/10.1016/j.vaccine.2011.04.066 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2010.07381.x .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1074/ jbc.M508696200 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1021/ja042792t .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1016/j.bbrc.2013.04.068 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1016/ j.febslet.2009.06.009 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1016/j.str.2011.11.015 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1172/JCI24617 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1016/j.vaccine.2012.12.053 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1038/31159 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1002/eji.200737322 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1038/ ni981 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1111/j.1462-5822.2012.01799.x .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
http://dx.doi.org/10.1016/j.cell.2007.05.059 .,OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
27:393– 422. http://dx.doi.org/10.1146/ annurev.immunol.021908.132703 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
68:621– 629. http://dx.doi.org/10.1128/IAI.68.2.621 -629.2000 .,Non-OADS,/arxiv_data1/oa_pdf/09/05/mBio.01262-14.PMC4049106.pdf
